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A study has been undertaken of the influence of thermal history on the
physical and dissolution properties of the polymer, polyethylene glycol (PEG)
4000 alone and its dispersions with trimethoprim. Of particular Interest
were thermal profiles which might be experienced during the manufacture
of molten filled hard gelatin capsules.
The effect of thermal history on the morphology of PEG 4000 was
established by DSC and X-ray diffraction studies. The previous thermal
treatment was found to Influence both the degree of crystallinity and the
crystal form, i.e. the relative proportions of extended and folded chain
crystals. Addition of a wide range of concentrations of up to 50% W/W of
trimethoprim did not particularly influence the crystallisation of the polymer.
Conversely, the crystallisatlon of the drug was found to be inhibited in the
presence of the polymer. However, no solid solution or eutectic formation
could be detected, and the phase diagrams oltained were of the monctectic
type for solid dispersions prepared under all conditions investigated. Studies
on the effects of ageing on these systems were also undertaken.
Further investigations of PEG 4000 and its dispersions were performed
by dielectric spectroscopy, which has not previously been applied to
pharmaceutical systems. This method allowed their structure and behaviour
to be characterised with greater definition over a range of temperatures and
during temperature cycling, in both the liquid and solid and thus offers
potential advantages over many previously utilised techniques.
Dissolution studies revealed that the dissolution rate of the polymer was
influenced by its degree of crystallinity, and that as this increased on ageing,
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so the speed of dissolution decreased. The mechanism of enhanced drug
release is complex, but the formation of an amorphous form of the drug and
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1 .1	 Background and definition of solid dispersions
The rate determining step in the absorption process for drugs of flow
or poor solubility is generally the dissolution rate of such drugs in the
gastro -intestinal fluids rather than their speed of diffusion across the gut
wall. From the Noyes -Whitney equation which describes dissolution
(Martinetal, 1969):
d.iC*_. kS (C - C*)
dt
where dC* Is the dissolution rate of the drug
dt
S is the surface area of the drug
... 1.1.
C - C is the concentration gradient, where C is the concentration of
drug in the thin saturated liquid film/bonndary layer adjacent to
the solid surface and C" is the bulk concentration of the drug in
the dissolution medium
kd is the proportionality constant related to the diffusion coefficient
of the solute and the thickness of the diffusion layer
it can be seen that one of the factors which controls the dissolution rate of
the drug is its surface area. Hence one possible method of improving the
dissolution rate would be to reduce the drug's particle size thus giving an
increased surface area. Methods by which particle size reduction has been
achieved include conventional milling and fluid energy micronisation
(Carter, 1972), controlled precipitation involving a change of solvent or
temperature (Scheikh et al, 1966), application of ultrasonic waves (Skauern,
1967) and spray drying (Kornblum and Hirschom, 1970). However, particle
size reduction by these techniques may not give a faster dissolution rate
- 30 -
due to subsequent agglomeration and aggregation of the resultant fine particles
which arises from their Increased surface energy. This was noted by Lin et
al (1968) who found that the in vitro dissolution rate of micronised griseofulvin
was slower than that of drug samples with a larger particle size. Another
disadvantage of fine powders of poorly soluble drugs is their poor wettability
and particles must be wetted as the first step of their dissolution in water.
Alternative techniques of particle size reduction have included administering
liquid solutions or water soluble salts which upon dilution with gastric fluids
precipitate the drug itself in the form of ultrafine particles (Levy, 1963 a).
Often, however, these methods are not possible in practice.
Seidguchi and Obi (1961) proposed that poorly soluble drugs should be
formulated as solid dispersions with water soluble carriers as a means of
achieving particle size reduction. Also, since the dissolution of a component
from a surface is affected by the second component in a multiple component
system (Higuchl, 1967), selection of a hydrophilic carrier should result in a
fast release of drug from the matrix. A solid dispersion is defined as a
dispersion of one or more active ingredients In an Inert carrier or matrix
in the solid state prepared by melting, solvent (ccprecipitate) or melting-
solvent methods (Chiou and Riegelman, l97L). This does not include dispersion
of active ingredients in solid diluents by traditional mechanical mixing. A
wide variety of materials has been investigated for suitability as carriers
and a summary is given In Table 1.1. One of the most frequently used
classes of carrier are the hydrophilic polyethylene glycols (PEGS), which
have even been advocated as universal carriers for solid dispersion
formulations because of their non-toxicity and compatability with most drugs
(Chiiu and Riegelinan, 1971), and it is this polymer which Is studied in the
work esented here.
- 31 -
Table 1.1.	 Examples of materials investigated as carriers for solid
dispersions
Carrier	 Workers
Polyethylene glycols	 Chiou and Riegelman (1971 )
Urea	 Sekiguchi and Obi (1961)
Deoxycholic acid	 Malone et al (1966)
Silicon dioxide	 Kim et al (1985)
Urethran	 Maulding (1978)
Polyvinyl pyrrolidcne	 Tachibana and Nakamura (1965)
Polyoxyethylene 40 stearate 	 Kaur et al (1 980a and 1 980b).
Renex 650 (polyoxyethylene- 	 Ford and Rubinstein (1978a)
nonyiphenylether)
Cetomacrogol 1000 	 Hoelgaard and M5 iler (197 5b)
Methylcellulose	 Kassem et al (1978)
Pentaervthritol	 Chiou and Riegelman (1969)
Pentaerythritol acetate	 Chiou and Riegelman (1969)
Poloxamer 188	 Reddy et al (1976)
Acrylic copolymer	 Larson and Banker (1976)
Succinic acid
	
Goldberg et al (1966)
Citric acid
	
Chiou and Riegelman (1969)
Mannitol	 McGinity et al (1975)
Sorbitol	 Ghariem et al (1980)
Glucose	 Ghanem et al (1980)
Maltose	 Gbanem et al (1980)
Dextrose	 McGinity et al (1975)
Galactose	 Allen et al (1977)
Sucrose	 Allen et al (1977)
Xylitol	 Sirenius et al (1979)
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1.2.	 Classification of solid dispersion systems
Solid dispersions may exist in a number of different physical forms
dependent on both the inherent properties of the constituent materials and
the conditions of manufacture. Chiou and Rlegelman (1971 ) proposed a
classification of binary pharmaceutical systems into six groups which are
outlined below. It should be noted that many of the theories they put forward
are drawn from the disciplines of geology and metallurgy and therefore
may be of limited applicability to pharmaceutical systems. This Is because
the properties and behaviour of pharmaceutical materials, which tend to be
relatively large organic molecules are often very different to those of metals
and small inorganic molecules.
1.2.1.	 Eutectic mixtures
Eutectics are two phase systems where the two components are miscible
in all proportions in the liquid state but are totally Immiscible in the solid
state (Reisman, 1970). On cooling fromthe melt, at a particular composition
known as the eutectic composition, the two components crystallise simul -
taneously from the melt to give an intimately blended physical mixture. This
eutectic has a unique melting point, which is lower than that of either of the
two constituents and the melting points of each component in excess of the
eutectic composition are depressed with respect to the pure materials.
This can be represented by the phase diagram shown in Fig. 1.1. Generally,
the eutectic of a poorly soluble drug shows an increased dissolution rate
relative to that of the pure drug and a number of explanations of this
enhancement have been postulated. These include a reduction in the particle
size of the drug ekiguchi and Ci, 1961), an increase in drug solubiity
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1966), absence of aggregation and agglomeration hiou and Riegelman, 1971 ),
improved wettability and dispersibifity (Sekiguchi and Obi, 1961) and crystal-
lisation of a more soluble, metastable polymorph hiou and Riegelman, 1971 ).
These possible mechanisms of dissolution enhancement will be discussed in
greater depth in Chapter 5.
1 • 2 • 2.	 Solid solutions
Solid solutions also known as mixed crystals, are homogeneous, one phase
systems made up of solid solute dissolved In solid solvent, which should
theoretically provide a faster dissolution rate than eutectic systems since the
particle size Is reduced to a molecular level, thus providing the maximum
surface area for dissolution (Goldberg et al, 1965). They can be subdivided
according to the extent of miscibility of the two components Into discontinuous
and continuous solid solutions. In the latter case, the two components are
miscible In all proportions in the solid state. Sodium bromide and silver
bromide form this type of solid solution (l'suji et al, 1969), but no
pharmaceutical system has bei shown to be able to crystallise in this manner.
With discontinuous solid solutions, the two components show only partial
miscibility with each other which can be represented by the phase diagram
in Fig. 1.2. It has been postulated that some degree of solid state miscibility
exists In most two component systems hiou and Riegelman, 1971 ) but In
many cases this degree of soluhility Is considered to be negligible.
An alternative method of classifying solid solutions is according to their
crystalline structure into substitutional, where one solute molecule
substitutes for a solvent molecule in the crystal lattice of the solid solvent
(Fig. 1.3.) and interstitial, where the solute molecule occupies the inter-








Flz. 1 .2.	 Typical pMse diagram of a discontinuous solid solution of
a binary system
1 .0	 Mole fraction	 1 .0
unsaturated solid solution
a	 liquid
b	 saturated solid solution a and liquid
c	 saturated solid solution (3 and liquid
d	 two conjugate solid solutions
e	 eutectic point
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FIg. 1.3.	 Schematic representation of a substitutional solid solution
o•o
y Dark circles represent solute atoms/molecules
Open circles represent solvent atoms/molecules
Fig. 1 .4.




so1uticxis to form, the size of the solvent and solute molecules must be as
cice as possible and the diameter of the solute molecules certainly should
nct differ by more than 15% from that of the solvent (Reed-Hill, 1964).
Ancther important factor is the degree of lattice distortion produced in the
solvent by the solute due to steric factors and chemical Interactions. For
example, naphthalene forms solid solutions with its a substituted halogen,
hydroxyl and amino derivatives but only eutectic mixtures with its /3
substituted derivatives hiou and Riegelman, 1971), indicating the degree
of molecular similarity required for substitutional solid solutions to form.
These constraints make it highly unlikely that pharmaceutical systems
consisting of two diverse chemical entities would form this type of solid
solution and indeed no drug-carrier system so far investigated has been shown
to have this type of structure.
With interstitial solid solutions, the relative size of the solute molecule
is again critical as the Interstitial volume of the solvent is limited. For
metals, the apparent diameter of the solute mclecule should be less than
0.59 of that of the solvent In order to obtain a solid solution (Reed-Hill, 1964).
From this, Chiou and Riegelman (1971 ) calculated that the volume of the
solute should be less than 20% of that of the solvent and on this basis suggest
that high molecular weight polymers, such as PEGS would be a logical choice
as carriers for insoluble drugs. They predict that on solidification, significant
amounts of drug will be trapped between the parallel helices of the PEG unit
cell.
- 38 -
1.2.3.	 Glass solutions and suspensions
Chiou and Riegelman (1969) first introduced the concept of glass solutions
as a method of enhancing the dissolution rate of drugs. Glass solutions are
homogeneous, cne phase systems, usually oltained by rapid quenching of
the melt to the amorphous form. Glass suspensions consist of precipitated
drug particles suspended in a glassy, solid solvent. Examples of carriers
which form glasses include citric acid (McGinity et al, 1975), succinic acid
(Chiou and Niazi, 1976), and the polymer polyvinyl pyrrolidone (Hcelgaard
and Møller, 1975b). Since the amorphous form of any compound possesses
the highest free energy, these systems may offer dissolution advantages over
even solid solutions. However, many of these systems are metastable and
wifi revert slowiy to the more thermodynamically stable but less soluble
crystalline form.
1.2.4. Amorphous precipitations in a crystalline carrier
On solidification, the drug may n crystallise but be precipitated as the
amorphous form within the crystalline carrier. As mentioned before, the
amorphous state possesses the highest surface free energy and should
dissolve faster than the crystalline form • For example, the amorphous form
of novobiocin has a ten fold higher solubility than the crystalline form
(Muilins and Macek, 1960). The properties of the carrier will have an
important Influence on the final structure of the drug dispersed within it.
With PEGS, the viscous nature of the melt may retard crystallisation of the
drug due to the difficulty of initiating nucleation and growth of crystals in
such a medium. The properties of the drug are also important, Chiou and
Riegelman (1971) have postuiated that if the drug supercools to any great
extent, then this will predispose it to solidify as the amorphous form.
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1.2.5. Compound and complex formation
Complexes formed between the drug and carrier may enhance or retard
the dissolution of the drug depending on their dissociation constant and
intrinsic absorption rate. Chiou and Riegelman (1971 ) stated that the rate
of dissolution and gastro- intestinal absorption may be increased by the
formation of a soluble complex with a low association constant. These
authors attributed the increased dissolution and absorption of griseofulvin
observed in dogs to the formation of such a complex (Chiou and Riegelman, 1970).
Conversely, the formation of a complex between PEG 4000 and phenobarbitone
was shown to reduce the amount of drug absorbed (ingh et al, 1966). Likewise,
decreased absorption of chiorthalidone in PEG 4000 solution compared to a
conventional tablet was ned by Williams et al (1982), even though the
presence of the polymer increased the solubility of the drug.
1.2.6. CombInation systems
The structure of a solid dispersion may n fall entirely Into any of the
categories described but may be a combination of several systems. Some of
the drug may exist in an amorphous form and some as micro-crystalline
particles, for example. This complexity may explain why so many solid
dispersion systems are difficult to categorise.
1 3.	 Methods of preparation of solid dispersions
1 .3.1.	 MeltIng or fusion method
This technique was first utilised by Sekiguchi and Obi (1961) who heated
a physical mixture of drug and carrier to just above its melting point in a
furnace, before solidifying the material rapidly in an ice bath under vigorous
stirring. The final solid mass was then milled and sieved. Subsequent
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modifications to this technique have involved mainly changes in the rate of
cooling of the solid dispersion. Cooling conditions employed have included
pouring the melt onto a glass slab (Hoelgaard and Moller, 1975a) or stainless
steel plate cooled by air blown on the opposite side of the plate Jhiou and
Niazi, 1976; Chiou and Riegelman, 1971 ); cooling in a dessicator at 40 C
(Kaur et al, 1980a and l980b) and stirring continuously under ambient conditions
until solidification occurred (Daabis and Mortada, 1980: El-Banna and Abdullah,
1980; SaId et al, 1974a and 1974b). Faster solidification rates have been
obtained by cooling the melt over a dry ice-acetone mixture (McGlnity et al,
1984), dry ice (Allen and Kwan, 1969; Brown, 1978) or by immersion in liquid
nitrogen (Hargreaves, 1982). In very few instances is the actual melting
temperature or time in the molten state recorded and reports exist where no
details of the heating and cooling conditions are given. This lack of control
of the thermal profile Indicates a lack of appreciation of the influence of
thermal history on the structure of these systems particularly where polymers
such as PEGS are used as the carrier.
1 .3.2. Solvent or c oprecipitate method
With this method, a physical mixture of the two solid components is
dissolved in a common solvent, followed by evaporation of the solvent to
leave a co-precipitate of the drug and carrier . It was first proposed by
Tachi±ana and Nakamura (1965) who prepared solid dispersions of 3 carctene
in polyvinylpyrrolidone and subsequently has been used on many occasions to
prepare co-precipitates of PEGS with a variety of drugs including griseofulvin
and tolbutamide (Kaur et al, 1980a), chloramphenicol (Kassem et al, l979a)
and hydrocortisone (Ho and Hajratwala, 1981). Although this may be a more
suitable method of preparation for drugs which undergo thermal decomposition,
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problems exist In finding a common, non-toxic solvent for the drug and
carrier and In complete removal of the solvent. Furthermore, the relative
cost of this method of preparation is high. Careful control of the processing
conditions such as the rate of evaporation of the solvent is essential to ensure
that the same crystal structure is produced where the drug or carrier can
exist In a variety of crystal forms.
1 .3.3. Melting/solvent method
An alternative to the melt nthod which may prove more suitable for some
drugs was described by Bajpai and Varma (1981) who dissolved the drug
amphotericin B in propylene glycol before mixing with molten PEG 4000 and
PEG 6000. However, the usefulness of this technique may be limited by the
problem of finding a solvent for the drug which is also miscible and compatible
with the carrier and by the fact that only a relatively small percentage of
liquid can be incorporated Into the carrier without significant loss of its solid
property, (Chicu and Smith, 1971).
1.3.4,	 Molten filling process
In spite of the potential advantages of these systems, as yet no commercial
solid dispersion dosage form has been marketed because of the difficulty in
manufacturing these materials on a large scale due to their poor processing
properties. Chicu and Riegelman (1971 ) noted that PEG solid dispersions
required hardening in a dessicator for at least 24 hours before they could be
pulverised. Even so, because of their wax- like nature they are difficult to
handle on high speed tabletting and capsule-filling machinery (Wells et al,
1975). Ford and Ruhinstein (1980) developed a method of granulating and
tabletting indomethacin - PEG 6000 solid dispersions. However, formulations
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containing more than 25% W1 drug would n tablet properly because they
were tacky and stuck to the upper punch in spite of hardening in a dessicator
for 12 hours prior to use. Where the indomethacin concentration was below
20% W/, the size of the tablet required to contain a therapeutic dose was
unacceptably large. Thus, for this system, only formulations containing
around 20% W/W could be tabletted successfully. Moreover, significant
decomposition of indomethacin occurred in the stored tablets, which was
later attributed to an interaction with one of the cxher excipients, magnesium
stearate (Ford, 1983). Recently, Walker et al (1980) have developed a process
by which liquids, including molten and thixotropic formulations can be filled
into hard gelatin capsules on an automatic filling machine. Since this
technique is discussed in Chapter 2.2., no further details will be given at
this point. However, it does overcome the aforementioned processing
difficulties associated with solid dispersions arid clearly increases their
commercial possthilities.
1.4. Advantages and possible applications of solid dispersions
Although first investigated as a method of Improving the dissolution rate
profile of poorly soluble drugs, solid dispersion systems, particularly in
the form of molten filled hard gelatin capsules, may offer advantages in
other respects which can be summarised as follows:
(I) The stability of unstable drugs may be improved by formulating them
In a suitable carrier, for example, oxidative degradation would be minimised
in a zero porosity matrix.
(ii) Incorporation of liquid or even gaseous compounds into solid dispersion
systems is possible. Chiou and Smith (1971) demonstrated that poorly water
soluble drugs such as clofibrate and dl-a -tocopheryl acetate could be
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successfully formulated In PEG 6000 by the melt method for concentrations
of the drugs up to lo%W/w
(ill) Operator handling hazards are decreased and risks of cross- contamination
reduced since no dust Is generated during the manufacture of molten filled hard
gelatin capsules. This is an Important consideration when handling toxic drugs
such as cytctaxics or allergenic materials such as antibiotics.
(iv) Content uniformity, especially of low dose drugs, can be Improved
since homogeneity within a melt system is more readily achieved than with
conventional powder mixes. Walker et al (1980) reported that molten filled
capsules containing a nominal 20 g of triamterene in PEG 1500 exhibited a
lower relative standard deviation in drug content and fill weight variation
than conventional powder fill capsules.
(v) Fast release priming doses may be incorporated into sustained release
products to provide the initial release of drug. Walker et al (1980) demon-
strated that this could be achieved using a matrix of PEG 1500 and polyvinyl
alcohol. Rapid Initial release of drug was observed due to dissolution of
drug dispersed in the water soluble PEG 1500 on the outside of the plug.
This was followed by a period of slower release dependent on the rate of
diffusion of water through the pores of the polyvinyl alcohol matrix.
(vi) Selection of a carrier with appropriate properties can be used to
obtain the release profile desired for the drug. For example, PEGS can be
used where a rapid release rate is required as would be desirable with oral
hypoglycaemics or analgesics (Geneidi et al, 1981; Froemming et al, 1978).
Alternatively, sustained release products may be obtained by using oil/paste
formulations as shown by FranoIs et al (1982).
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1.5. Morphology of PEG 4000
Polymers in the solid state have a complex morphology because of the
chain like nature of the constituent molecules which gives rise to crystallisation
behaviour and morphologies rarely encountered in small molecule solids,
whether organic or inorganic. Knowledge of the morphology of polyethylene
glycols is therefore necessary to aid understanding of their behaviour when
formulated as solid dispersions, since the structure of the polymer may
greatly Influence that of the drug and hence the properties of the system.
1.5.1.	 General formula





which readily polyrnerises to form long chain molecules of the general
formula HO- H2CH29)nH, where n is the number of ethylene oxide units
or the degree of polymerisaticxi. A wide variety of molecular weights is
available ranging from 200 to several million. Lower members of the group,
up to molecular weights of appraximately 1000 are liquid at room temperature
but PEGS of higher molecular weight are hard waxlike solids In appearance
(Hoechst, 1977).
1.5.2. Crystallisation
Crystallisation can be defined as the formation of an ordered state from
a disordered one which involves nucleation and growth of the new phase
within the parent phase. In the molten state the polymer chains are randomly
orientated, although some evidence exists for association of the chain ends
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(Shimada et al, 1980). As the temperature is lowered, nucleation of crystals
can occur by one of two mechanisms.
Homogeneous nucleation involves the random spontaneous aggregation of
polymer chains below the melting point. This process is reversible up to
the point at which a critical nucleus size is reached, above which subsequent
addition of chains is Irreversible and growth commences. The closer the
crystaillsation temperature appronches the melting point, the larger this
critical nucleus size is required to be, resulting in the development of only
a few nuclei for crystaffisation. Conversely, as the temperature is lowered,
the critical size of the nucleus required for growth decreases, resulting In
the formation of a large number of small nuclei (Meares, 1966). However
decreasing the temperature also results in a rapid increase in viscosity which
hinders the diffusion of polymer chains through the melt, thereby reducing
the rate of nuclei formation. Thus a maximum rate of crystallisation occurs
at a temperature where the Influence of nucleation and diffusion controlled
mechanisms is weakest. If the viscosity of the polymer melt is very high or
the temperature is lowered very rapidly, then crystal growth will be inhibited
altogether. The polymer will solidify as a glass where the constituent
molecules retain the random orientation of the liquid state.
Heterogeneous nucleation arises from nuclei which are already present
in the melt and occurs effectively instantaneously, unlike homogeneous
nucleation where a finite time is required for the appearance of nuclei.
Heterogeneous nuclei may arise from many sources such as extraneous solid
impurities, grain boundaries and cavities distributed either randomly
throughout the bulk or localised, for example at the surface of the container
of the melt (Sharples, 1966). It has also been suggested that thermodynamically
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stable minute crystals of polymer with a very high degree of crystalline
perfection persist in the melt above the observed bulk melting point (Morgan,
1954). The number, size and stability of such crystal nuclei depend on a
number of factors such as time and temperature of melting and previous
crystallisation history, which are discussed in section 1 .6.
For PEGS, the presence of heterogeneous nucleation sites can be
demonstrated • In a thin film of polymer which was crystallised, melted and
recrystallised, out of 28 crystallisation sites observed on the first crystal -
lisatic*i, 24 appeared in identical positions on the second crystallisation,
(Barnes et al, 1961).
Growth of nuclei is thought to proceed by polymer chains diffusing to the
surface of the crystal, where they are pleated into position on the growth
face (Hillier, 1966). Crystal growth continues until it is arrested by mutual
impingement of growing crystal structures. Many workers have derived
equations to describe the overall crystallisation kinetics including Avrami
(1939, 1940, 1941) and Hoffman and Lauritzen(196l), but in the case of PEGS,
the crystal growth does nc follow the predicted kinetics in general (Beech et
al, 1972a; Godovsky et al, 1972). The morphological features developed
from the melt are now discussed in the following section (1.5.3.).
1.5.3. Morphological features developed from the melt
PEGS are semi crystalline polymers which in the solid state will consist
of bh crystalline and amorphous regions, in varying proportions according
to their previous thermal history. Factors which affect the crystallinity of
the polymer are discussed in section 1 .6. Total crystallinity is never achieved
in any circumstances because of the presence of chain ends, short chain
fragments and impurities which cannot pack into crystals and are rejected to
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form the amorphous phase.
In the crystalline state, PEG chains exist as a double parallel helix
containing seven monomer units H2CH2G) and two helical turns per fibre
identity period of 93 nm. The crystallographic unit cell is monoclinic and
contains four molecuiar chains, (Bailey and Koleske, 1976). The chains
have two axes of symmetry, one passing through the oxygen atoms, the other
bisecting the carbon-carbon bond. Internal conformations in the solid about
the OCH2, CH2CH2 and CFI2O bonds have been assigned as trans. gauche
and trans respectively (Koenig and Angood, 1970). The polymer chains form
plateLike crystals, known as lamellae, with the chain ends rejected onto the
surface layer and with the helical chain axis normal to the lamella (Kovacs
et al, 1975). In the lameUae, polymer chains are either fully extended or
folded a small integer number, c, of times (Arlie et al, 1966, 1967) (Fig.
1.5 (a) and (B)). In chain folded crystals, the chain folds are tight with
adjacent re-entry. Hydrogen bonding between 01-I groups of the chain ends
on the surface of the lameUa contributes to the stability, especially of the
extended chain form. It is interesting to note that the melting points of
phenaxy or chloro terminated polyethylene oxides are much lower than those
of the hydraxy terminated PEGS for this reason (Booth et al, 1972). Extended
chain crystals (ecc) are found in PEGS of molecular weights up to about
4000, at which point folded chain crystals (fncc) start to be detected and
above PEG 6000, the folded chain morphology predominates. The number of
folds per molecule depends to some extent cxi the molecular weight but is also
influenced by crystallisation conditions. For PEG 4000, at least extended
and once folded crystals can be formed and for this molecular weight, the
latter are metastable with respect to the former. Conversion to the fully
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Fig. 1.5. Diagram of cross-section through part of a lamella showing:
(a) Polymer chains in extended chain crystal form
(b) Polymer chains in once-folded chain crystal form
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extended form through chain unfolding and lamelia thickening will occur under
suitable conditions. Evidence for the formation of twice folded crystals of
PEG 4000 exists, but they are very unstable so that transformation to the
next lowest chain conformation readily occurs (Kovacs et al, 1977). The
proportion of ficc formed will increase as the crystalilsation temperature
decreases i.e. as the crystallisation rate increases, indicating a preference
for this morphology in a rate controlled crystallisation process (Beech et al,
1972a). This can be observed for PEG 4000 on a graph of crystal growth rate
as a function of iscthermal crystallisation temperature which reveals several
discontinuous branches, each of which corresponds to an integral value of
n(Fig. 1.6.).
The kmellae are in turn organised into spherical structures, usually
spherulites, but also hedrites which may range from 4 jm to 1 cm in diameter
according to the crystallisation conditions (Bailey and Koleske, 1973).
Spherulite8 are symmetrical birefringent structures with fine radiating
branches from a central nucleus. The polymer chains usually lie at right
angles to these radial units and hence tangentially with respect to the nucleus.
Under crossed polaroids, spherulites composed of ].ameUae which do nct twist
as they extend from the apparent nucleus display a dark maltese cross. By
comparison, a maltese cross superimposed by concentric extinction bands
is observed where lamefla twist regularly as they extend outwards (Mien
and Mandelkern, 1982). Hedrites have a layered or steplike appearance,
apparently grown from a central screw dislocation and appear very similar
to spherulites in many respects. However, the maltese cross effect is lost
when viewed normal to the basal plane which suggests that one optical axis
is perpendicular to this plane (Mikhailov et al, 1978). Under certain
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Fig. 1.6.	 Crystal growth rate as a function of temperature of
crystallisatii for PEG 3900 (Kovacs & Gonthier, 1972)
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conditions, a morphology which is neither uniquely spheruLitic or hedritic
In character can be produced.
1.5.4.	 Melting
Unlike low molecular weight materials, polymers do nct show a unique
melting point but meJt over a range of temperature which may be up to
100°C wide. For PEGS, the melting temperature range Increases with
molecular weight up to PEG 6000, above which It remains practically the
same since for higher molecular weights, the melting point becon s
determined by the thickness of the ]amella rather than the length of the
chains, (Hoechst, 1977). Melting temperature can be considered to be a
function of molecular order or crystallinity and will therefore be influenced
by such factors as the previous temperature of crystallisatlon. Samples
which have been cooled rapidly from the melt will contain many small
crystallites which possess a higher energy per unit volume of crystalline
material than would a single large crystal. Furthermore, surfaces between
crystallites are regions of poor packing and therefore behave as inherent
crystal imperfections, all of this tends to lower the melting point (Meares,
1965). Conversely, samples which have been cooled very slowly will contain
larger, more perfect crystals which will possess a higher melting point.
Chain ends which are excluded from the crystals also act as imperfections
to depress the melting point, an effect which becomes less important as the
molecular weight increases since the relative proportion of chain ends
decreases (Sharples, 1966). Finally, the crystal type of the polymer can
influence the melting temperature. For PEG 4000 which can crystallize as
extended chain or once folded chain crystals, the latter are thermodynamicaUy
metastable with respect to the former and consequently melt at a lower
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temperature (Kovacs et al, 1977).
1 .6.	 Factors affecting the structure of PEG
1.6.1. Time in the molten state and temperature of melting
These factors wifi influence the degree of chain entanglement and the
stability, number and size of surviving nuclei in the melt which in turn govern
the subsequent crystaflisation rate and size of spherulites developed from the
melt. At temperatures nct too far in excess of the equilibrium melting point,
much if the crystalline conformation of the polymer chain is retained
(Matsuura and Miyazawa, 1969), but the persistence of ordered chains in
the melt will decrease as the melting temperature or time in the molten state
increase. This can be seen from the decreasing number of surviving nuclei
observed in samples of polyethylene oxide crystallising at 52.7°C as the
temperature at which the polymer had previously been melted increased (Fig.
1.7.). Dependence of crystallisatiou rate on the melting temperature has
been reported for PEG 6000 (Hay et al, 1969). Changing the melting temperature
from 80°C to 100°C decreased the rate of crystallisation at 54°C by a factor
of thirty, but changing the melting temperature from 100°C to 150°C produced
no significant alteration in the crystallisation rate. Although this data Implies
that above a certain temperature, the history dependence of the sample will
disappear, this is n always so. Even if nuclei are destroyed by the high
temperature, they can be reformed in cavities or ou the surface of foreign
particles on cooling to below the melting point (Beech et al, 1972). Furthermore,
during the molten filling process, it is desirable that the temperature of the
melt is kept as low as possible, certainly below 100°C to minimise thermal
















!!g. 1.7.	 Number of heterogeneous nuclei In a sample of polyethylene
oxide crystallising at 52 .7°C plotted as a function of the




changes in the temperature of melting and time in the molten state would be
expected to exert the greatest influence CTL the subseçuent crystallisation
process and final structure of the polymer.
1.6.2.	 CooLingrate
The rate at which a polymer cools from the melt Is probably the single
most important factor In determining its structure and hence its properties
in the solid state. Crystallisation studies have been confined largely to
ishermal crystallisatlon, where the melt is supercooled to a defined
temperature and held there, or to rapid quenching of the melt by immersion
in liquid nitrogen. However, for most pharmaceutical systems, including
the molten filling of solid dispersions into capsules, knowledge of what happens
under non-iscthermal conditions is necessary to interpret their behaviour,
although much information can be inferred from iscthermal studies.
Since polymer chains In the melt are randomly orientated, a finite
time is required for the nucleation and growth of ordered crystals by chain
diffusion through the melt. Thus as the rate of cooling increases, the time
for diffusion decreases and becomes hampered by such factors as high
viscosity, leading to a decrease in the crystallinity of the polymer. In the
extreme case of quenching from the melt, the polymer chains are frozen in
their random orientation giving the amorphous form. As this form possesses
the highest free energy, it would be expected to have the greatest solubility
but also to be the least stable.
For less dramatic rates of cooling, the number of nuclei formed for
crystallisation will be dependent on the cooling rate. At relatively slow
cooling rates, only a few nuclei will form, resulting in the growth of very
large spherulites. Conversely, faster cooling rates will give rise to many
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small nuclei and bence a large number of small spherulites will crystaUise
out. Under Isothermal conditions, extended chain crystals preferentially
form at high crystallisation temperatures, but with large degrees of super-
cooling, folded chain crystals become the dominant morphology in PEG 4000
(Kovacs et al, 1975, 1977). An increase in the percentage of amorphous
material would be expected at faster cooling rates reflecting the insufficient
time for orientation and crystallisation of the polymer chains. Beyene (1981)
has demonstrated that even relatively small changes in cooling rate from
7.5° CHr 1 to 3.75° CHr' affected significantly the mechanical strength
of PEG 6000 due to morphological differences in the structure of the polymer
which it is expected would influence other properties as well.
1.6.3. Ageing
Little work has been published on the morphological changes associated
with the ageing of polyethylene glycols alone. However, after the completion
of the primary crystallisation process, secondary processes are known to
occur harples, 1966). These result in a very slow and continual increase
in crystaillnity often over a period of many months due to perfecting of the
existing crystal structure. Crystallisation of the slowly crystallisable
components or part of the amorphous region may take place. For PEG 4000,
the crystal form may change from the metastable once-folded chain crystal
to the completely extended chain crystal by a process of chain
unfolding leading to an increase in the thickness of the ]ameliae (Kambe, 1980).
All of these changes will be accelerated by annealing the polymer at a
temperature a few degrees below its melting point.
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1.6.4. Effect of adding a second component (usually drug)
In addition to forming either a eutectic or solid solution system with the
polymer as outlined in section 1.2., the added material may have one of
several other actions on the crystaffisation of the polymer and thereby
influence the final structure of the system. If the added material is present
as undissolved or recrystallised particles, it may act as a nucleating agent
to increase the number of nuclei present in the polymer melt. This will
result In a marked Increase In the crystallisaticxi rate of the polymer, as
was observed when 2% W/ lead phosphate was added to PEG 6000 (Beech et
al, l972b). Moreover, crystallisatlon may well take p]ace at a higher
temperature which for PEG 4000 mIght predispose the formation of the more
thermodynamically stable extended chain crystals. Rapid crystallisation of
the polymer would also hinder any further crystal g-rowth of the other
component. Therefore the speed of crystallisation of the PEG may influence
the size of the crystals farmed by the second component. The nucleating
ability of a substance is difficult to predict since the mechanism Ly which
nucleation is induced is not well understood. It is important to note that the
mere presence of foreign particles in the melt is not sufficient to initiate
nucleation, since for example, addition of mercury droplets to PEG melt
resulted In no increase in nucleation -Iay et al, 1969). The surface energy
of a substance does not appear to dictate its nucleating ability since both high
and low energy surfaces have been shown to be capable of acting as nucleating
agents by Chatterjee et al (1975a). However crystallinity of the added material
has been Identified by these authors as a necessary but not sufficient require-
ment for nucleating ability.
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The added material could also act to Inhibit crystallisation of the polymer
by hindering chain diffusion and packing resulting a higher percentage of
amorphous and imperfectly crystalline material. Studies of the crystallisation
of PEGS have shown that low molecular weight fractions and foreign material
which would include the drug) are rejected during the primary crystallisation
process, giving a boundary layer of non-crystallisable or slowly crystallisable
material and foreign particles at the growth front (Beech et al, 1972b). In the
solid state, this wi II constitute an amorphous region between the crystalline
Iamellae.
1.7. Methods of studying the structure of solid dispersions
1.7.1. X-Ray Diffraction
Since X-rays are scattered by a crystal according to Bragg's Law, the
pattern and intensity of X-ray diffraction froni a sample measured as a
function of diffraction angle will be characteristic of the material (Vainshtein,
1966). With two component systems, the situation Is more complex and a
number of possibilities exist. For eutectics, the X-ray diffraction pattern
is simply a composite of those of the individual components, whereas with
solid solutions the position of the diffraction lines may alter. In the case of
substitutional solid solutions, the diffraction lines associated with the solvent
crystal may or may nc* shift according to the size of the solute molecule;
while for interstitial solid solutions, the position of diffraction lines associated
with the solvent again may or may n change but those of the solute disappear
hiou and Riegelman, 1971 ). Complex formation is relatively easy to detect
since lattice parameters will always change. Likewise, polymorphic
modifications of either the drug or carrier will display different diffraction
patterns.
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Althcugh X-ray diffraction is a useful technique for investigating the
structure of crystalline compounds, it cann be used to examine amorphous
materials, since these scatter X-rays randomly, giving a spectrum consisting
of a diffuse 'hump'. This can cause problems also in discriminating between
an amorphous precipitation and an interstitial solid solution of drug within a
carrier, since in neither case are diffraction peaks of the solute observed.
Such difficulties have been experienced in the interpretation of data obtained
from systems where low levels of drug were dispersed in PEGS (Chiou and
Riegelman, 1971 ).
1 .7.2. DifferentIal scanning calorimetry
Differential scanning calorimetry (DSC) is a technique of non -equilthrium
calorimetry where the sample and reference materials, heated at a linear rate,
are kept isothermal by changing the current through the heater below the two
chambers. By monitoring changes in current, thermal transitions such as
melting or polymorphic changes can be measured. The predominant use of
DSC in the investigation of pharmaceutical solid dispersions has been the
accurate determination of thaw and melting point temperatures over a range
of compositions of carrier and drug, (e.g. Hcelgaard and MØller, 197.5a and
b; Ford and Ruhinstein, 1978b; El-Banna and Abdallah, 1980). From this
data, a phase diagram of the system can be constructed which should be
characteristic of the type of solid dispersion formed. However, information
other than simply the melting point of the sample can be obtained from both
the shape of the peaks and the area of the transition curve such as the heat
of fusion or crystallisation.
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1 .7 .3.	 Hot stage microscopy
Hot stage microscopy (HSM) Is another method which has been used widely
in the construction of phase diagrams of pharmaceutical solid dispersion
systems (e.g. Ford and Rubinstein, 1978b; Hargreaves, 1982). A thin film
of solid dispersion on a microscope slide is heated at a constant rate and
observed under crossed polar oids. Crystalline material will appear illuminated
against a dark background but on melting, crystaUlnity is lost and any structures
disappear. The melting point data recorded from this technique are obviously
subject to operator error and have been reported to be much less reliable than
those obtained by DSC (Chiou and Riegelman, 1971 ; Chang et al, 1975). With
polymers such as PEGS, the melting points determined by the disappearance
of birefringence are 3 0_ 50 C lower than those determined by thermal analysis
methods iay et al, 1969). Furthermore, only the thaw and final melting
points can be detected by HSM and any intermediate transitions are not
observed.
1.7.4.	 DissolutIon rate
Allen and Kwan (1969) proposed a new method for studying what they term
the degree of crystallinity in solid-solid equilibria, which they define as the
ratio of crystalline drug to that dispersed at a molecular level within a
carrier. They compared the dissolution rates of 10% W/w indomethacin in
PEG 6000 constant surface area discs prepared by the fusion method with
those of a physical mixture and from this data constructed a graph of the
degree of crystallinity of Indomethacin as a function of dissolution rate.
In this method, the authors assume that the indonthacin in the physical
mixture was entirely crystalline and in the fusion formulation existed entirely
as a molecular dispersion, but no experimental evidence in support of this
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was given. Furthermore, the effect on dissolution of the different particle
size distributions in the two formulations has nct been taken into account.
Thus this technique suffers from a number of theoretical and practical
limitations.
1.7.5.	 Other methods
I.R. spectroscopy has been utilised on several occasions to determine
whether any cornplexation existed between PEG and the dispersed drug
-Iargreaves, 1982; Kassem et al, l979b). A number of cther methods have
been used to examine the polymer alone which have rarely if ever been
applied to the study of pharmaceutical solid dispersions. These include
nuclear magnetic resonance spectroscopy (Maxfield and Shepherd, 1975;
Matsuzaki and Ito, 1974), Raman spectroscopy (Koenig and Angood, 1970),
dielectric spectroscopy (Decossas et al, 1982), diatometry (Ikeda et al,
1975; Price et al, 1975), mechanical relaxation (Hartmann, 1972), electron
spin resonance spectroscopy(T8rmala et al, 1973; Lang et al, l977a and b)
and scanning electron microscopy (Lovinger et al , 1976). It is possible
that a number of these techniques would yield valuable information about the
structure of solid dispersions as well.
1.8. Aims of this work
The importance of thermal history in determining the structure and
prcperties of solid dispersions, especially those involving polymers has uct
been appreciated fully. Therefore, the primary aim of this work is to
Investigate the structure of PEG 4000 and its solid dispersions with a model
drug under various controlled heating and cooling profiles with particular
reference to conditions which might be experienced during a molten filling
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process. The Influence of any changes on the dissolution rate of both the
drug and the polymer will be determined. Additionally, structural changes
which occur on ageing will be investigated and related to changes In
dissolution behaviour.
Difficulties exist In assessing the structure of polymer-drug dispersions
in the solid state by conventional techniques which frequently do not provide
an unambiguous description of these systems. Thus the second aim of this
study is to evaluate a new method of investigating the structure and
behaviour of PEG 4000 and Its solid dispersions, namely dielectric response.
Previous work performed by Shablakh (1982) has already proved the usefulness
of this technique in folling structural changes on heating and cooling in the
cycloalcohols. It Is proposed to compare this new technique with
established pharmaceutical procedures such as D.S.C. and X-Ray diffraction.
CHAPTER 2
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CHAPTER 2 Materials and Process Characterisation and Solid Dispersion
Preparation
2.1.	 Characterisation of materials
2.1 • 1.	 Polyethylene glycol 4000
From the wide range of molecular weights available, PEG 4000 was
selected as a model because it displays a number of interesting morphological
features since bh folded chain and extended chain crystals can be formed
depending on the crystallisation conditions (see Chapter 1). Secondly, many
dissolution studies e.g. Geneidi et al (1980) and Kassem et al (1980) have
shown that molecular weights of PEG of this order give the greatest
dissolution enhancement of the drug.
The sample of PEG 4000 used In this study was supplied by Hoechst
(Batch no. 82133) in the form of hard, white flakes. DSC of the polymer
showed that samples melted in the expected range for this molecular weight
and details of the technique and results are discussed in Chapter 3, as are
the X-ray diffraction studies performed on the material.
One of the most important characteristics of a polymer is its molecular
weight distrthution and knowledge of this is vital in interpreting physical
data. Polymer samples are never monodisperse since during manufacture,
the growth and termination procedures which determine the size of Individual
molecules are often random in nature. This polydispersity wifi affect
properties such as melting point, mechanical strength and crystallinity
because on crystallisation, shorter chains in a sample may nX pack into
crystals as easily as longer chains, leading to fractionation and attenuation
of crystal growth (Beech et al, 1972b). Molecular weight analysis was
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therefore carried out (at R .A . P.R .A. Technology Ltd., Shaw bury) by gel
permeation chromatography, a technique which involves non-aqueous
fractionation of the different molecular weights by molecular sieve. A
0.1% W1 solution of PEG 4000 In dimethyl formamide at 80°C was passed
down a P.L. gel column at 0.5 mi/mm. Calibration of the column was
carried out using polyethylene oxide standards. From the results, a graph
of the molecular weight distribution can be oht ained (Fig. 2.1.) and the
number average (Mn) and weight average (Mw) molecular weights calculated.
The ratio of Mw/Mn gives the polydispersity factor of the material and
provides a useful Index of the heterogeneity of the molecular weight
distrthution. In a monodisperse sample, Mw/Mn would be unity, but as the
breadth of the distribution increases, so does this ratio. For this sample
of PEG 4000, Mn was found to be 4390 and Mw 4960, giving a polydispersity
factor of 1.129 which Indicates a narrow molecular weight distribution and
hence there was no need to fractionate the polymer further.
2.1.2. Trimethoprim
The model drug needed to fulfil certain basic criteria which can be
listed as follows:
() Chemical stability
(b) Compatibility with PEGS
(c) Easy to assay in aqueous solution
(d) Low solubiity in water
(e) Polar nature so that dielectric studies possthle
The antibacterial drug t rimethoprim complied with all these requirements
and, in spite of the fact that it does nct suffer from bioavai]ability problems,
was felt to be a suitable model for these studies. Moreover, Meshali et al
.I
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(1983) have demonstrated that an increase In dissolution rate allowing a
corresponding dose reduction is possible with sugar glass dispersions of
trimethoprim, which might also be expected for PEG dispersions.
Trimethoprim, which has the structure shown in Fig. 2.2. was supplied
by Hoechst, Iatth number L008/OFTTOO, in the form of a fine white powder.
The absence of polymorphic forms was confirmed by DSC as only a single
excthermic peak at 202°C was observed, which corresponded to Form I of
trimethoprim (Bettinetti et al, 1976). X-ray diffraction analysis of the
powder produced the expected characteristic spectrum. Details of,and
results obtained from,these two techniques will be discussed further in
Chapter 3.
Particle size analysis was carried out using a Coulter Counter Model TAIl
( oulter Electronics, Harpenden) with a 0. 9%"/v aqueous solution of s odium
chloride, previously saturated with trimethoprim as electrolyte. The drug
was found to have a geometric mean diameter of 10.58 jm (geometric
standard devIation 1.46 jim). Scanning electron microscopy (Phi lips, Model
5OlB) confirmed the particle size data from the Coulter Counter and also
revealed the particles had very broken crystalline surfaces consistent with
having undergone micronisation (Plate 2.1.).
2.1.3.	 Other chemicals used
All cxher chemicals used in this work e.g. for assay procedures are
listed in Table 2.1. together with the supplier, grade and batch number.
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Fig. 2.2.
	 Chemical structure of trimethoprim
NH	 OCH
® N H2 )_C H 24JOCH3
2, 4_diamino_5_[3', 4', 5'-trimethoxybenzyl] pyrimidine






Table 2. 1. Details of chemicals used in this work
Chemical	 Grade	 Supplier	 Batch number
Hydrochloric Acid 	 AR	 Flsons,	 73
Loughborough
Iodine volumetric 	 AR	 BDH Chemicals 	 7563 990C
solution	 Poole, Dorset
Barium chloride	 AR	 BDH Chemicals	 9124647H
Poole, Dorset
2.2. Characterisation of the thermal profile of the process for molten
filling of hard gelatin capsules
2.2.1.	 Introduction
Walker et al (1980) have recently described the use of an adapted Zanasi
LZ64 automatic capsule filling machine to fill molten formulations, where
the dosator tubes and powder hopper have been replaced with a liquid filling
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pump and heated reservoir. A schematic diagram of the system is given in
Fig. 2.3. MaterIal is pumped from a heated reservoir through a precision
pump (Hibar, HBD-1A) and filled into the capsules which are then ejected In
the usual manner. A detector system operates to stop the filling cycle if a
capsule body Is not present and thus prevents soiling of the turntable by the
melt. If a capsule body is missing, light from the diode reaches the detector
below the turntable and triggers a microswitch which halts filling. As long
as a capsule body is present, no light will reach the detector.
During the filling process, material from the same batch will not be
subjected to the same heating and cooling conditions. For example, the
material will have been in the molten state for a variable length of time,
depeoding on whether it was fified towards the beginning or end of the run.
The temperature of the melt in the reservoir may fluctuate during filling.
Thirdly, the rate of cooling of the capsules as they are ejected may vary
according to their position in the collecting container. As all these factors
are known to affect the morphology and hence physical properties of semi-
crystalline polymers such as PEGS, it is important to quantify the thermal
profile which might be expected and any possible sources of variation which
might occur. The effect of different heating and cooling profiles cii the
structure of the solid dispersion can then be fully Investigated and if
necessary, temperature controls can be applied at critical stages during
processing. Therefore the degree of variation in thermal history during
a typical run using the filling system described above was investigated.
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A 1tch of approximately 3 kg of PEG was filled into size 3 capsules
(fill weight 120 mg) on the adapted Zanasi LZ64 machine. After initially
melting the material at 70°C In an oven, it was transferred to the heated
reservoir, maintained electrically at 65°C. The temperature at different
positions in the reservoir (Fig. 2.4.) was monitored throughout the run
using a digitron temperature probe (Model 175, Digitron Instrumentation).
The time spent in the molten state was also recorded.
On ejection from the filling machine, capsules were collected into a
cylindrical container of diameter 30 cm and height 20 cm. The temperature
of the capsules at three different levels in the bulk container was recorded
as a function of time using the digitr cxi probe as above. The time taken as
zero was when the probe was placed in position as the capsules collected in
the container, which took approximately 20 minutes to fill. Cooling profiles
were also obtained for the contents of individual, isolated capsules, by
Inserting the temperature probe directly into the opened capsule after filling.
2.2.3.	 Results
A graph of the temperature fluctuations with time at various positions in
the reservoir is shown in Fig. 2.5. A variation of approximately 8°C in the
temperature of the melt at different points in the reservoir was observed, with
the coolest material being at the surface in the centre as might be expected.
During the run, however, the temperature of the material in the reservoir
did n vary by more than 2-3°C, even though the volume of the melt decreased
as filling proceeded and no stirring was carried out. The time that the
material spent in the molten state ranged from 1 to 7 hours.
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Fig. 2.4.	 Positions in the heated reservoir at which the temperature









Position 1: Exit port at base
Position 2: Surface of melt, In the centre
Position 3: Surface of melt, at the side
Position 4: Half-way down melt, at the side











Fig. 2.5. Temperatures at different positions In the heated reservoir
as a function of time
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A wide variation was observed in the time that capsules at different levels
in the container took to cool to ambient temperatures (Fig. 2.6.) ranging from
1 hr 40 mm (capsules on top) to 6 hours (capsules in the middle). Temperature
profiles of capsules in the middle and at the bcttom of the container showed a
rise in temperature of several degrees foUowed by a plateau region before
cooling commenced, which was not observed with capsules on top of the
container. Cooling rates (excluding plateau region) were approxImately 11,
7 and 6°Chr4 for the top, bottom and middle positions respectively. The
cooling profile for individual capsules followed the behaviour shown in
Fig. 2.7. In all samples studied.
2.2.4.	 DIscussion
The range of time that the material spent in the molten state varied
between 1 and 7 hours, even for a relatively small batch and might weU be
expected to increase with larger batch sizes. It is Important, therefore,
that influence of this factor on the final structure of the polymer is known.
Less variation was observed In the temperature of the melt during the run,
although again, more variation may be expected with larger batch sizes.
The rise in temperature and subsequent plateau region seen for the
cooling profiles of capsules in the bottom and middle of the collecting container
Is presumably due to the heating effect from warmer capsules on top as they
are ejected from the machine. However, some ccntribution arising from the
excthermic heat of crystallisation of the polymer may be involved. Larger
collecting vessels migit be expected to enhance this temperature gradient,
resulting in even greater variations in cooling rates. Individual capsule
cooling profiles show a sharp drop in temperature when supercooling of the







Fig. 2.6. Temperature profiles of capsules cooling at different
positions in the collecting container








Fig. 2.7.	 Characteristic cooling profile of an individual capsule




temperature occurs due to the exothermic reaction associated with crystal-
lisatlon of the polymer. Cooling to room temperature occurs when this
transition is complete.
2.2.5.	 Conclusions
The study carried out above illustrates that capsules from the same
batch may have significantly different thermal histories, and the Importance
of this on the properties of the formulation should be Investigated.
2.3.	 PreparatIon of solid dispersions
2.3.1.	 Preparation of samples with different thermal histories
Solid dispersions with different thermal histories were prepared by a
fusion method as follows. Quantities of PEG 4000 alone or a physical
mixture of polymer and trimethoprim were melted in an oven (LTE Ltd.,
Oldham, Lancashire) at the required temperature. Subsequently, melts
were transferred quickly into either a brass mould with 1.5 cm diameter
holes, which produced the discs for dissolution studies or glass slides for
examination by X-ray diffraction. The temperature of melting, time in the
molten state and rate of cooling of the samples was controlled by means of
a clearspan P1O5T programmer attached to the oven, which also provided a
record of the thermal cycle actually undergone. Some of the samples were
cooled very rapidly from the melt by immersion in liquid nitrogen. DSC
was performed on both discs and slides to ensure that no significant
difference in structure resulted from this change in size and shape. Similarly,




A range of samples of PEG 4000 and polymer-trimethoprim solid
dispersions prepared under different conditions were stored In amber glass
bottles protected from light at 25°C, 37°C and 45°C. Changes in
dissolution rate and in structure of both polymer and drug as determined
by X-ray diffraction and DSC were monitored immediately after preparation
and at various intervals up to six months. For every composition, at least
duplicate determinations were performed at each time interval. Scanning
electron micrographs were oltained for representative samples.
CHAPTER 3
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CHAI'rER 3 Investigation of structure by DSC, X-ray diffraction and SEM
3.1.	 Introduction
In this chapter, the application of conventional techniques, namely DSC
and X-ray diffraction to the study of PEG 4000 and its solid dispersions is
investigated. Since the basis of these techniques has been outlined already
in Chapter 1.7., no further introduction to them will be given here.
Although many studies have been performed on the dissolution properties
of PEG solid dispersions, relatively few investigations of their physical
structure exist • Most workers have characterised these dispersions by
constructing phase diagrams, either by DSC or hct stage microscopy
(e .g. Ford and Rubinstein, l978a; Hoelgaard and Møller, l975b), using X-ray
diffraction to substantiate the results obtained from the thermal methods.
For most PEG solid dispersion systems investigated, formation of a eutectic
at low drug concentrations, typically below 10%"/w drug (e.g. Hoelgaard
and Meller, l975a; Daabls and Mortada, 1980) has been suggested. Other
authors have postulated that a degree of solid-solid solubility exists below
the eutectic point (e.g. Hargreaves, 1982). However, no unequivocal evidence
for the formation of either eutectics or solid solutions has ever been found
from X-ray diffraction data. Recently, McGinity et al (1984) suggested that
the PEG solid dispersions they studied by X-ray diffraction existed simply
as a physical dispersion of drug in the polymer. Thus considerable confusion
exists in the literature about the structure of PEG solid dispersions, possibly
due to the properties of the polymer Itself. Therefore, the first part of the
studies described in this chapter concentrate on the behaviour of PEG 4000
alone under different thermal treatments.
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3.2.	 Methods
3.2.1.	 Differential scanning calorimetry
A differential scanning calorimeter (Model DSC -1, Perkin Elmer Ltd.,
Beaconsfield) coupled to a galvanometric chart recorder (Model PRR, Texas
Instruments, Houston, USA) was calibrated as recommended by the
manufacturers using pure materials which melt in the temperature range of
interest, namely gallium (mpt = 29.7°C) and indium (mpt = 156.6°C).
Samples of between 4 and 5 mg, depending on composition, were weighed to
0.01 mg (Model 1712, Sartorius, Belmont, Surrey) and sealed into aluminium
sample pans. Thermograms were obtained at a heating rate of 80C min1
and a range of 8 mcal sec -1 unless ctherwise stated, in a nitrogen atmosphere.
AU determinations were carried out at least in duplicate. Transition
temperatures, as determined by the peak maximum method (Wendlandt, 1974)
and peak areas were recorded using a graphics tablet connected to a micro-
computer (Model III-, Apple).
The heat of fusion or crystaffisation was calculated with reference to the
indium standard eat of fusion, Hf = 28.43 kJ kg'). From these values,
the crystal]in.ity of the polymer was estimated by assuming that the heat of
fusion of a perfectly crystalline sample of PEG was 196.78 kJ kg (Buckley
and Kovacs, 1976). Thus:
% crystallinity of PEG =
	
x 100	 ... 3.1.
Where 4AHf = observed heat of fusion
= heat of fusion of perfectly crystalline polymer
- 82 -
3.2.2.	 X-Ray diffraction
Diffraction patterns were obtained using an X-ray diffractometer (Philips,
New Jersey) with CUKa radiation, wavelength 0.154178 nm, by scanning at
1 0
 min in terms of the 20 angle over a range from 50 to 350• Duplicate
scans were run In all cases. The interplanar d-spacings were calculated
according to Bragg's Law:
=2dsinO	 ... 3.2.
where nA= order of reflection
X= wavelength of x-rays
d = distance between planes of atoms
0= angle of incidence
The intensities of the diffraction peaks were measured and expressed as a
percentage of the height of the most intense peak. Degree of crystallinity
was estimated by the usual method (Sharples, 1966) based on the relation:
% crystallinity =	 Oc	 x 100	 ... 3.3.
Oc + kxOa
where Oc and Ca denote measures of the crystalline and amorphous intensities
respectively. The constant, k which accounts for the relative scattering
intensity of both phases, was taken to be unity as Is the convention (Bartel et
al, 1979). After a straight background line had been drawn, the diffraction
pattern was resolved into its amorphous and crystalline parts as shown in
Fig. 3.1. Determination of the areas was performed using a graphics tablet
in conjunction with a micro computer (Model 11+, Apple).
3.2.3.
Scanning electron micrographs were obtained (Microscope Model 501B,









sellctape and sputter coated with gold to a depth of 10-15 nm using an E.M.
sputter coating unit (Model E5100, Polaron, Watford).
3.3.	 Results and discussion
3.3.1.	 PEG 4000
3.3.1.1.	 Temperature of melting
Initial investigations of the melting behaviour of PEG 4000 as received
by DSC revealed only one melting enddherm with a peak maximum temperature
(I'p) of 57 . 00 C (l'able 3.1.) which corresponded to the melting of the extended
chain crystal form (Bailey and Koleske, 1976). The average value of the heat
of fusion (Hf1 ) was 179.20 KJKg 4 , equivalent to a crystallinity of 91%,
which Is in agreement with values from the literature which are quoted as
between 167.5 and 193 KJKg depending on crystallinity (Hoechst, 1977).
After samples had been melted at temperatures of between 60 0 C and 200°C
for 10 minutes they were cooled to room temperature at 8°C min'.
Crystallisation exherms exhibited only one transition, except for the sample
melted at 60°C, where a low temperature shoulder to the peak was observed.
Furthermore, the peak crystaUisation temperature for this sample of 26 .5°C
was higher than for any of the cxher samples which crystallised at 22°C.
The lowest melting temperature of 60°C is only just above the melting point
of the polymer and it is expected that re]atively large numbers of heterogeneous
nuclei will persist in the melt, allowing crystallisation to begin at a higher
temperature as the molten PEG 4000 is cooled. Destruction of these nuclei
for crystallisation by raising the temperature of melting delays the
subsequent recrystallisation as the melt is cooled. Thus samples melted
at 800C or above exhibited a peak crystallisation temperature which was
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Table 3.1.
	 Effect of melting temperature on PEG 4000, samples cooled
at 8°C min
Temperature of
	 60	 80	 100	 150	 200
melting (°C)
I
•	 H11 (KJ Kg ')	 181.71 177.10 179.61 180.03 177.94Initmi
melting
Peak melting	 57.0	 57.0	 57.2	 57.0	 57.1
temperature (°C)
	
(KJKg)	 168.73 169.98 168.31 163.7 164.96
Crystal-	 _______________________________
lisation
Peak crystallisation	 26.5	 21.8	 22.0	 22.5	 21.0
temperature (°C)
	
Hf2 (KJKg')	 169.57 169.98 172.08 169.57 168.31
-	 Peak melting tempe-	 52.0	 52.0	 52.4	 52.5	 52.2
rature (lower) 0C
2nd	 Peak melting tempe-	 56.7	 56.4	 57.0	 56.8	 57.2
melting	 rature (upper) °C
% of lower peak area	 60
to tctal area
% of lower peak height 	 51
% crystallinity	 86
64	 65	 71	 77
52	 54	 56	 59
86	 87	 86	 86
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some 4_50C lower than samples crystallised from 60°C. Heats of
crystallisation (H.) were always 5-10% less than the respective heats of
fusion due to an increase In the amorphous fraction, which arises from the
material which is rejected during this primary crystallisation process and
crystallises only very slowly or not at all.
Subsequent remelting of the polymer invariably produced a melting
endotherrn with two distinct transitions, with peak melting temperatures of
—'52°C and 57°C which can be assigned to the melting of once folded and
extended chain crystals respectively (Buckley and Kovacs, 1976).
Representative melting, crystallisation and remelting thermograms are
shown in Fig. 3.2. The effect of coolixg PEG 4000 at a slower rate was also
investigated by preparing samples In the oven at a cooling rate of 0.33°C
min' (20°C hr 1 ). Subsequent examination of these samples byDSC
revealed similar melting behaviour to th at a cooling rate of 8°C mln1
(l'able 3.2.). Under both cooling conditions, the percentage of folded chain
crystals formed, as measured by the ratio of the lower melting peak area to
the total area, increased as the previous temperature of melting was raised
(Figs. 3.3. and 3.4.). This increase was reflected also in the relative
Increase in the peak heights of the lower temperature transitions, which are
shown on the same diagrams. However, a higher proportion of extended
chain crystals was formed under all melting conditions with samples cooled
at the slower rate of 20° C hr 1 . No significant difference in the position
of the two melting peaks nor in the total heat of fusion on remelting was
observed. It is known that the crystallisation temperature has a marked
effect on the relative proportion of the two crystal types (Beech et al, 1972a).





































% of lower peak area
to tctal area
% of lower peak height
% crystauinity
60	 80	 100	 150	 200
	
172.5	 175.8	 173.8	 170.8	 171.2
	
52.0	 52.8	 52.2	 52.2	 53.0
56.5	 57.0	 56.8	 56.8	 57.4
35	 39	 39	 43	 45
26	 27	 28	 29	 31






Relative proportion of folded chain crystals formed as a
function of the previous temperature of melting
60 80 100	 150	 200








Fig. 34.	 Relative proportion of folded chain crystals formed as a
function of previous temperature of melting
(samples cooled at 20°C hr1)
60 80 100	 150	 200




in the proportion of the higher melting point extended chain crystals and vice
versa. Thus, as previously mentioned, increasing the melting temperature
will destroy surviving nuclei in the melt, tending to decrease the temperature
at which crystallisation commences predisposlng the formation of folded chain
crystals.
A typical X-ray diffraction spectrum of PEG 4000 as received together with
the d-spacings and relative peak intensities are presented in Fig. 3 .5. and
Table 3.3. respectively. The degree of crystallinity was determined to be 94%
which Is in good agreement with that calculated from the calorimetric measure-
ments. Variations in the melting temperature, under either cooling condition.,
did not alter the diffraction spectrum from that of the original material,
although a small decrease in crystallinity to 90% occurred in both cases as
was observed also from the DSC data.
3.3.1.2.	 Time in the molten state
Samples of PEG 4000, melted at temperatures from just above the melting
point of the polymer up to 200°C , were maintained in the molten state for
periods of time ranging from 10 minutes to 10 hours before being cooled at
200C hr4 to room temperature and subjected to DSC and X-ray diffraction
studies.
The melting endotherms of some samples did not show two distinct peaks,
but rather a low temperature shoulder to the main higher temperature
melting peak, or in the case of samples kept at 200 0 C for 10 hours, two very
broad overlapping peaks. The proportion of folded chain to extended chain
crystals could not be calculated where this occurred (Table 3.4.).
At 600 C, the time in the molten state does not seem to influence particularly











	 d-spacings and relative intensities of X-ray diffraction peaks
for PEG 4000
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nor the peak melting temperatures (l'able 3 .4. (a)) changed significantly,
indicating that no degradation of polymer chains had occurred. Furthermore,
the proportion of folded chain to extended chain crystals obtained on
crystallisation from the melt remained virtually unchanged even after 10 hours,
with a predominance of the extended chain type.
Although little difference was seen at 100° C for samples melted for up
to 1 hour, there was a slight decrease in the heat of fusion for samples of
PEG 4000 maintained at this temperature for 10 hours (Table 3.4.(b)).
A more marked decrease in the heat of fusion from 171 .2 to 153.7 KJKg4
resulted after melting the polymer for 10 hours at 200°C (l'able 3.4.(c) and
FIg. 3.6.), with a consequent decrease of approximately 3°C In the peak
melting temperatures. Furthermore, the melting endotherms obtained for
these samples were very broad and commenced some 5°C lower than those
for cther samples. After 10 hours at either 100°C or 200°C, polymer melts
turned yellow, as is often observed when PEGS are kept at high temperatures
for long periods (Hoechst, 1977). An increase in the amorphous halo of the
X-ray diffraction spectrum was apparent after melting at 200°C for 10 hours,
but no other changes were observed. This instability of PEG 4000 to
prolonged heating results from the break up of the polymer chains into lower
molecular weight fragments. These cannot pack effectively into the crystals
and tend to be rejected during the crystallisaticii process, resulting in a
larger fraction of amorphous material, which is reflected in the decreased
heats of fusion measured. However, long melting periods at high temperatures
seem to be required before appreciable break up occurs and below 1000C,
degradation of polymer chains is minimal.
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Table 3,4.
	 Effect cf time in molten state on PEG 4000
(a) Temperature of melting = 60°C
Time in molten state
10 mins	 1 hour	 10 hours
Hf2 (KJKg 1 )	 172.5	 171.2	 171.7
Peak melting temperature (lower) °C	 52.0	 53.0	 52.9
Peak melting temperature (upper) °C	 56.5	 57.0	 58.0
% lower peak area to total area
	 35	 -	 -
% lower peak height
	 20	 26	 24
% crystallinity	 88	 87	 87
(b) Temperature of melting = 100°C
Time in molten state
lOmins	 lhour	 10 hours
Iif2
 (KJKg)	 173.8	 168.3	 163.3
Peak melting temperature (lower) °C	 52.2	 52.4	 53.0
Peak melting temperature (upper) °C	 56 .8
	 57.2	 57 • 5
%lowerpeakareatotctalarea	 39	 -	 -
%lcwer peak height 	 28	 26	 18
% crystallinity	 88	 86	 83
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Table 3.4. cont.
(c) Temperature of melting = 200°C
lOmins	 moken 10 hours
Hf2 (KJKg 1 )	 171.2	 167.5	 153.7
Peak melting temperature (lower) °C	 53.0	 52.0	 50.0
Peak melting temperature (upper) °C	 57.4	 56 .0	 54.0
% lower peak area to total area	 45	 -	 -
% lower peak height 	 35	 40	 38












Effect of time In the molten state on the enthalpy of











Following melting at 100°C, samples of PEG 4000 were cooled at rates
ranging from rapid quenching in liquid nitrogen to cooling at 5°C hr*
After cooling at the slowest rate, 5°C hri, PEG 4000 displayed only one
endothermic transition at 57°C arising from the melting of extended chain
crystals and a relatively high degree of crystallinity-91%, when investigated
by DSC (Table 3.5.). This high degree of crystallinity was confirmed by the
X-ray diffraction pattern, which was unchanged from that of the original
polymer. Presumably the slow cooling rate favours the formation of extended
chain crystals, since crystallisation at higher temperatures may take place,
although isothermal crystallisatioii studies suggest that the limiting temperature
above which only this type Ct crystal is formed is around 55°C (Beech et al,
l972a). Alternatively, annealing of folded chain crystals which may be formed
initially could occur during the slow cooling process, resulting in chain
extension.
DSC thermograms of polymer samples cooled at faster rates of between
033°C mind and 32°C mm 4 revealed that two melting peaks reappeared
indicating the presence of bcth folded and extended chain crystals. A gradual
increase was noted in the proportion Of folded chain crystals formed up to
-. 72% at a cooling rate of 32°C mm 4, indicating a preference for this crystal
type in a rate-controlled process as reported by Beech et al (1972a). From
their isothermal studies, the proportion of folded chain crystals was found to
increase as the crystallisaticn temperature was lowered with a consequent
increase in the crystallisation rate. No changes in the melting temperatures
of either folded or extended chain crystals were observed. The slight decrease
in the heat of fusion for these samples, especially those cooled at 32°C min4,
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in comparison to PEG 4000 cooled at the slowest rate of 5°C hf' reflected
bcth the higher proportion of folded chain crystals and a decrease in their
crystalline perfection.
PEG 4000 was found to be extremely difficult to quench and a completely
amorphous form could ncX be produced by immersing samples in either
cardice or liquid nitrogen. Quenching in cardice or liquid nitrogen did
nevertheless reduce the crystallinity to 79% and 46% respectively. DSC
thermograms of these samples showed somewhat surprisingly that the lower
melting peak disappeared rather than the higher temperature transition,
Indicating that crystallisation which occurred took place in the extended chain
form. Similar findings were reported by Guven and Sengar (1978) from their
investigations of the melting behaviour of irradiated and quenched PEG 4000.
However, the peak transition temperatures of these samples were some 2°C
lower than those recorded for the melting of extended chain crystals produced
from more slowly cooled material, suggesting that the crystals formed were
extremely small and contained many defects. Visual examination tended to
confirm this since no spherulites were seen and much of the material was
glassy and transparent in appearance. X-ray diffraction spectra of PEG 4000
quenched in liquid nitrogen (Fig. 3.7.) showed that peak heights were markedly
reduced with a corresponding increase in the amorphous halo.
3.3.1.4.	 Effect of ageing
The effect of ageing on PEG 4000 was investigated by foUowing changes in
the structure of samples cooled at different rates after storage at 25, 37 or
45°C for periods of up to six months. Under all storage conditions studied,
irrespective of their previous thermal history, an increase in the heat of













Effect of ageing on various samples of PEG 4000
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Fig, 3,8,	 (c) Stored at 45°C
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only 24 hours especially where the polymer had been quenched In liquid
nitrogen previously. The increase in crystallinity was most rapid for polymer
stored at the highest temperature of 45°C, but even at 25°C, changes in
structure occurred relatively quickly. Most of the observed increase in the
heat of fusion took place in the first two months of storage at all temperatures.
After six months, all samples exhibited approximately similar heats of fusion
indicating an equivalent degree of crystaUinity. X-ray diffraction data
substantiated these results and confirmed tbe degree of crystallinity present.
No new diffraction peaks appeared and although some minor changes in the
relative intensities of the peaks occurred, these were simply due to changes
in the preferred orientation in particular samples.
The DSC thermograms of PEG 4000 cooled at 20°C hr showed that a
gradual conversion from folded to extended chain crystals occurred,
resulting in the disappearance of the lower temperature melting peak
(Fig. 3.9.). This conversion was most rapid at a storage temperature of
450 C, since chain unfolding can take place more easily as the melting point
of the polymer is approached. The polymer samples cooled at 5°C hr
contained the largest Initial percentage of stable extended chain crystals and
the highest degree of crystallinity. Thus the changes observed on ageing at
any of the storage temperatures were small in comparison to the other two
hatches, since only a limited amount of annealing could take place in these
samples. Nevertheless, the small fraction of folded chain crystals present
were converted to the extended chain form and the degree of crystallinity
did increase slightly.
The most dramatic increase in crystallinity on ageing was observed in

















Fig. 3.9. DSC thermograms of PEG 4000 after ageing for different










the residual crystalline regions present acted as nuclei for recrystallisation
of the amorphous fraction. The melting point of the initial samples before
ageing was approximately 55°C and corresponded to the melting of extended
chain crystals. As already stated, this was some 2°C lower than that
measured for this crystal form in cther samples of PEG 4000 but was
probably due to the small size of crystals which were formed and their high
degree of imperfection. During ageing, the rise in the degree of crystalLinity
was mirrored by a concurrent increase in the melting point of the crystals
to the expected value for extended chain crystals of 57°C. However, the
melting points measured for this crystal type of PEG 4000 cooled at either
20°C hr' 1 or 5°C hr' Initially did n change by more than 0.5°C during
the period of storage. This would be expected, since the melting point Is
influenced by the thickness of the lamella, which cannot increase once the
extended chain form is present.
These ageing studies seem to indicate that reversion to the most stable
crystal form of the polymer - extended chain crystals for this molecular
weight - wifi eventually occur regardless of the initial structure or the
temperature of storage, providing sufficient time is allowed. Even slowly
cooled samples of PEG 4000 do nX exist in a tctally stable state and will
change slowly with time. The changes in structure which occur are
accelerated by higher storage temperatures, since lamella thickening and
recrystallisation will be facilitated, but the final level of crystallinity is
almost equivalent at all storage temperatures after 6 months.
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Plate 3.1.	 Electron micrograph of PEG 4000 spherulites
5%W/w trimethoprim dispersion
Plate 3.2.	 Electron micrograph showing lamellar structure of
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Electron micrograph of PEG 4000 spherulites 
5% w /w trimethoprim dispersion 
Electron micrograph showing lamellar structure of 
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Plate 3.4 . 
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Electron micrograph of 10%W /w trimethoprim-PEG 4000 
dispersion 
IOOJlm 
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Fig. 3.10.	 Partial phase diagram for PEG 4000 -trimethoprim system,
previously melted at 100°C for 10 mins and cooled at 20°Chr,
constructed from DSC melting transition data
Phase transitions:
A Trimethoprim
0	 PEG 4000 - extended chain crystals
• PEG 4000 - once-folded chain crystals
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alcohol and PEG 6000, which had nct been melted together previously. In
this latter case, as here, no melting transitions were observed by DSC for
the drug at concentrations of 10%W/w or less. It appears that at low
concentrations, very gradual dissolution and melting of the drug occurs
which cannnt be detected by DSC. Depression of the melting point of
trimethoprim, due to the presence of the polymer diminished as the drug
concentration rose. No melting point depression of the polymer by the drug
was apparent, except for 50%"7w dispersions where a small decrease of
2°C was observed. This is again similar to the results reported by
Hargreaves (1982) on heating physical mixtures of betamethasctie alcohol
and PEG 6000, where the melting point of the polymer was depressed by up
to 6.5°C, apparently by the physical presence of the drug. It is interesting
to ne that Harrison and Runt (1980) reported that single crystals of
polyethylene embedded in tctally incompatible matrices of nther polymers,
with which no chemical reaction was possthle, showed a melting point
depression of up to 5°C. The effect was most marked where the matrix
was crystalline rather than amorphous. This degree of depression would
be a significant part of that reported for compatible systems.
Although the phase diagram suggested that no eutectic or solid solution
was present, there is some degree of uncertainty as to the behaviour at
low concentrations of trimethoprim since no melting transition for the drug
could be detected in this region. However, additional Information about
the structure can be obtained if the enthalpies of fusion for the polymer and
drug are plcxted as a function of the percentage weight of the polymer. A
typical diag-ram where a eutecticis formed, for the PEG 4000-water system
(Hager and Macrury, 1980), Is illustrated in Fig. 3.11. If a eutectic point
- 114 -
Fig. 3.11.	 Enthalpy of melting oltained by DSC as a function of % weight























exists, then the enthalpy of fusion of the non-polymeric component per gram
of sample should decrease as the concentration of the polymer Increased,
eventually to zero at the eutectic point. The enthalpy of fusion of the eutectic
should increase as more eutectic forms, reaching a maximum at the eutectic
composition and then decreasing as excess polymer is added. This decrease
is paralleled by a rise In the enthalpy of fusion of the crystalline PEG 4000.
A simi]ar diagram constructed for this system (Fig. 3.12.) revealed
that although there was a decrease in the enthalpy of melting of trimethoprim
at high concentrations of PEG 4000, it did nc fall to zero, as might have been
expected for a eutectic system. Furthermore, there was no appreciable
Increase In the enthalpy of fusion of PEG 4000 as has been reported by
Prud'homme (1982) for the solid solution formed between PEG 4000 and
PEG 1000. There, the presence of the small percentage of PEG 1000
molecules trapped inside the PEG 4000 crystals resulted in an apparent
increase in the heat of fusion of the latter. The only change in the enthalpy
of melting of PEG 4000 here however, was a small decrease at high concen-
trations of trimethoprim. This probably arises from the high concentration
of drug particles hindering the orientation and diffusion of polymer chains
in the melt, resulting In a lesser degree of crystalline order and hence
lower heat of fusion. The observed decrease in the heat of fusion of
trimethoprim as Its concentration decreased, may reflect the fact that
gradual dissolution of the drug in the polymer melt is also occurring.
X-ray diffraction patterns of these samples were found to be composites
of those of the two individual components, except below 2%W/w trimethoprim,
where no diffraction lines characteristic of the drug could be detected.















Fig. 3.12.	 Enthalpy of melting obtained by DSC as a function of % weight
of PEG 4000, for trimethoprim solid dispersions previously













a number of solid dispersions are presented in Fig. 3.13. and the d-spacings
for polymorphic form I of trimethoprim In Table 3.6. Although a second
polymorphic form of trimethoprim is known to exist (Bettinetti et al, 1 976),
it did not appear to be present to any detectable extent in the original powder
or the solid dispersions.
As expected where the drug did not dissolve completely In the polymer
melt, the subsequent dispersions existed as a physical dispersion of drug
particles in the polymer matrix. A different structure might be expected
and in fact has been reported (e.g. Hargreaves, 1982), where the two
components have previously been fused together. However, a similar phase
diagram i.e. monctectic, was oltained with solid dispersions which had
been prepared by totally melting the polymer and drug at 200°C, prior to
cooling at 60°C hr. A faster rate of cooling than from 100°C was chosen
to minimise thermal degradation (Fig. 3.14.). Moreover, a similar
relationship existed between the enthalpy of melting and percentage
composition (Fig. 3.15.). The melting points of both PEG 4000 and
trimethoprim were not significantly changed from those measured for the
physical dispersions. X-ray diffraction spectra were again composites of
the two components but diffraction peaks of trimethoprim were absent at
concentrations below 5% W/w . No polymorphic forms of trimethoprim were
detected, in either the dispersions or in samples of drug which had been
fused and cooled, nor was there any significant decrease in the intensity of
the diffraction peaks.
An alternative to using DSC melting data to construct a phase diagram is
to use the crystallisation data (Smith and Pennings, 1977). Additionally,
this should provide information as to whether PEGS inhibit the crystallisation




Fig. 3.13. Typical X-ray diffraction spectra for trimethoprim and its
and its solid dispersions with PEG 4000 previously heated













Table 3.6.	 d-spacings and relative intensities of X-ray diffraction peaks








Fig. 3 .14.	 Partial phase diagram for PEG 4000 - trimethoprim system,
previously melted at 200°C for 10 mins and cooled at
600Chr ,
 coustructed from DSC melting data
LU
Composition (% "/w trimethoprim)
Phase transitions:
A Trimethoprim
o PEG 4000 extended chain crystals
• PEG 4000 once-folded chain crystals
4E
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Fig. 3.15.	 Erithalpy of melting obtained byDSC as a function of % weight
of PEG 4000, for trimethoprim solid dispersic*is previously
melted at 200°C for 10 mins before cooling at 6O°Chr




















of drugs dissolved In them, as has often been suggested (El-Banna and
Abthljah, 1980; Salib et al, 1976) but never conclusively demonstrated.
DSC thermograms of the crystaUisation exotherms of solid dispersions of
PEG 4000 and trimethoprim melted at 200'C for 10 mins and cooled at
8°C mln were ol:tained. The relatively rapid cooling rate was chosen
because faster cooling is known to facilitate the formation of eutectics
and solid solutions, due to the lack of time for complete fractionation of
the two components (Prud'homme, 1982).
On cooling the pure drug, which melted at 202°C, a significant degree
of supercooling occurred before recrystallisation at 149°C. Qviously
though, the amount of supercoolingwill be dependent on the cooling rate
used. Only one exothermic peak was observed, thus it is likely that only
one polymorphic form of trimethoprim recrystaflised. This was confirmed
on remelting, since these samples displayed only one endothermic peak as
before. If the other known polymorphic form of trimethoprim had also been
present, then a second transition at — 170°C would have been observed,
corresponding to the conversion of the metastable Form U to Form I
(Eettlnetti et al, 1976). CrystaUlsation transitions for trimethoprim could
only be detected for concentrations between 2O%"/w and 50%W/w. Below
this, only one excthermic peak arising from the crystallisation of PEG 4000
was observed. The phase diagram and enthalpy of crystallisation as a
function of polymer composition data (Fig. 3.16. and 3 .17. respectively)
are again of the pattern obtained earlier.
Below 2O%"/w trimethoprim, where no recrystallisation peak for the
drug is observed, a number of explanations for this behaviour can be






Fig. 3.16.	 Partial phase diagram for PEG 4000 - trimethoprim system
constructed from DSC crystallisatl1n data, fused at 200°C
for 10 mins and cooled at 8°C min



























Fig. 3.17.	 Enthalpy of crystaUisatiai obtained byDSC as a function of
% weight of PEG 4000, for trimethoprim solid dispersiciis










a possible reason. However, no corresponding Increase is observed in the
enthalpy of crystallisation of the transition attributed to PEG 4000, nor does
the extrapolated curve for the enthalpy of crystallisation of trimethoprim
fall to zero. Alternatively, the technique of DSC may be too insensitive to
detect the heat of crystaLlisatlon of small amounts of drug in the molten
polymer. However, the most likely explanation would be that the crystallisation
of the drug Is Inhibited to a certain extent in the polymer melt due to its high
viscosity. Thus on cooling, some of the drug molecules fail to recrystallise
and are rejected by the growing polymer crystals as foreign impurities.
Thus, they are forced into the amorphous regions which exist between the
crystal branches of spherulites and in between ]amellae. This suggestion
is consistent with the X-ray diffraction data observed for disperions which
previously had been fused tctally, where the absence of diffraction peaks for
trimethoprim below 5%W/w drug could be due to the presence of the drug in
an amorphous form. It is difficult to envisage the formation of a solid
solution of drug Inside the polymer lameliae, since foreign particles and
even low molecular weight chains are rejected by the growing crystals.
Furthermore, considerations of the size of the interstitial space available
within the PEG helix suggest that trapping of drug molecules between the
paraUel helices of PEG chains, as has been postulated by Chiou and
Riegelman (1971) is nct feasible. The cross-sectional diameter of the PEG
helix Is of the order of 0.5 urn (l'akahashi and Tadokoro, 1973) which would
be insufficient to accomm(xlate trimethoprim molecules and still allow
crystallisatlon of the polymer.
Thus from theoretical considerations of PEG morphology, crystallisation
and from the data presented in this section, it appears that negligible solid
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solution or eutectic formation occurs between PEG 4000 and trimethoprim.
Nevertheless, the structure of bcth components may be influenced by the
her and by their thermal history, further studies of which are presented
In the following sections.
3.3.2.2.	 Temperature of melting
As the morphology of PEG 4000 was found to be dependent on its previous
thermal history hapter 3.3 .1 .), the addition of a second component was of
interest in terms of the effect on bth the drug and the polymer. A represen-
tative range of concentrations of trimethoprim, 2%w/w 10%'Vw and 5O%N/W,
were chosen for study. After melting at temperatures of between 60°C and
200°C for 10 minutes, samples were cooled at 8°C min to room temperature.
Dissolution of the trirnethoprim particles in the polymer melt as assessed
visually was incomplete for 2%"/w dispersions below 100°C, for 1O%W/W
dispersions below 150°C and at all melting temperatures except 200°C for
so%w/w dispersions.
DSC melting endotherms for all samples showed two lower temperature
transitions corresponding to the melting of once folded and extended chain
crystals of PEG 4000 as before uckley and Kovacs, 1976). In addition,
the 5o%w/w solid dispersions displayed a third endothermic peak which
resulted from the melting of the drug. The observed melting temperatures
and enthalpies of fusion for PEG 4000 in the 2%W/w dispersions were nt
significantly different to those for the polymer In the absence of the drug.
At a trimethoprim concentration of 1O%''/w, a slight decrease in the
enthalpy of fusion of —5% compared to the polymer alone was observed,
whereas the melting temperatures were unchanged,for samples previously
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melted at 1 50°C or 200°C. However, for 50%'"/w dispersions, a decrease
in bcth the melting temperature, of — 2°C and the enthalpy of fusion, of
— 10% in relation to the pure polymer was apparent where the previous
melting temperature exceeded 100°C. The percentage of once folded chain
crystals increased with the previous temperature of melting (Fig. 3.18.),
as was observed for PEG 4000 alone. Differences between dispersions
containing various concentrations of trimethoprim were not very marked,
and the proportion of each crystal type formed was of the same order as
PEG 4000 in the absence of any drug. Nevertheless, there appeared to be
slightly more folded chain crystals in samples containing 50%"Yw
trimethoprim at all melting temperatures studied.
X-ray diffraction studies did not reveal any new diffraction lines for
any of the dispersions, indicating that no polymorphic forms of trimethoprim
had appeared. The characteristic peaks for trimethcprim were absent In
2%"/w dispersions melted at 100°C or above, but present in the diffraction
patterns for all other samples, which were composites of the two components.
Apart from a slight increase In the amorphous halo for 50%"Vw dispersions
melted at 150°C or 200°C, there were no detectable changes in crystallinity.
Overall, these results suggest that at low concentrations of drug, around
2%"/W, the presence of the drug does not interfere significantly with the
crystallisatlon of the polymer. This appears to be true for both the
crystaUine drug, as was present in the dispersions melted below 100°C,
and for the amorphous form, as was probably present in dispersions
previously melted at or above 100°C. At this low concentration, trimetho-
prim which dissolves or melts in PEG 4000 does not seem to recrystallise






Fig, 3 .18.	 Relative proportion of folded chain crystals formed as a function
of previous temperature of melting for various concentrations
of trimethoprim In PEG 4000 dispersIons
20	 60 80 100	 150	 200





as the temperature is lowered, and crystallisation of the polymer commences,
drug molecules will be rejected as impurities by the growth front of the
crystal and form part of the amorphous region (Beech et al, 1 972b). At
this concentration, no effect on crystaUinity is detectable. Trimethoprim
which is present as particles does not appear to nucleate crystallisatlon of
the polymer to any significant extent.
At a concentration of 1O%"/w trimethoprim, there Is rio evidence to
suggest that the drug present in particulate form behaves as a nucleating
agent. As for 2%W/w dispersions, some of the drug in dispersions previously
melted at high temperatues does not recrystallise on cooling and exists in
the amorphous state. Some disruption of the crystallisation process of the
polymer is apparent from its reduced enthalpy of fusion and hence crystallinity
with samples melted at 150°C or 200°C.
For low melting temperatures below 100°C, the presence of 50%W/w
trimethoprim on the morphology of PEG 4000 was not marked. The decrease
in the melting temperatures and enthalpies of fusion for dispersion previously
melted at or above 100°C indicates that a higher proportion of amorphous
material is formed. This, together with the higher percentage of metastable
folded chain crystals formed suggests that the crystallisation of the polymer
is hindered. Reasons for this may include the higher viscosity of polymer
melts contaIning 50% W/w trimethoprim which will decrease the mobility
and rate of diffusion of the polymer chains. A decrease in the temperature
at which crystallisation took place would favour the formation of a higher
percentage of folded chain crystals. Also, crystallisation of the polymer
in the presence of a high concentration of drug particles would be hindered
simply because the growth of the crystals would have to take place around
- 131 -
the drug particles, resulting in a less perfect crystalline structure.
3.3.2.3.	 Time In the molten state
The effect of the time in the molten state on solid dispersions of
trimethoprim and PEG 4000 was studied, with respect to its influence on the
subsequent morphology produced, rather than the kinetics of degradation of
the drug at elevated temperatures. Investigations were performed as for
PEG 4000 hapter 3.3.1.2.) except that only times of 10 minutes and 10
hours were studied.
The behaviour of dispersions containing 2%w/w trimethoprim was very
similar to that of PEG 4000 alone with an equivalent degree of reduction In
the enthalpy of fusion and melting temperatures under all conditions studied.
For dispersions of 10%W/w or 50%W/w trimethoprim maintained in the
molten state for 10 minutes, a slight reduction in the enthalpy of fusion and
melting temperatures was observed by DSC and X-ray diffraction studies,
especially at high melting temperatures. These results have been discussed
in the preceding section. After 10 hours at 200°C, 10%"/w dispersions
were very yellow and displayed a very brond melting endotherm with a
markedly reduced heat of fusion. 50%"/w dispersions maintained at 100°C
or 200°C far 10 hours failed to recrystallise on cooling to room temperature,
and were dark yeUow-brown in colour, indicating that significant decompo-
sition of the polymer and probably the drug also had occurred. However,
at the lowest melting temperature studied, 60°C, the dispersions remained
relatively stable, even after 10 hours, as was observed for PEG 4000. The
effect of time in the molten state at different temperatures enthalpy of
fusion of the various dispersions is illustrated in Fig. 3.19. As would be








Fig. 3.19. Effect of time in the molten state on the enthalpy of fusion of
various solid dispersiais of PEG 4000 and trimethoprim
20	 60	 100	 200
Temperature of melting (°C)
+ 2% W/,y trimethoprim	 0	 2% W/w trimethoprim
Z 10% "Lw trimethoprim	 10% W/ trimethoprim
• 50% ' "/w trimethoprim
	
*	 50% /w trimethoprim
Time in melt 10 mins	 Time in melt: 10 hours
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to thermal degradation and chain scission of the polymer. The rate of
degradation of the melt appears to accelerate considerably above —100°C.
3.3.2.4.	 Cooling rate
As the rate of cooling from the melt was shown to exert a strong effect
on the subsequent morphology of PEG 4000, the influence of this variable on
the morphology of its solid dispersions is of particu]ar interest.
Quenching In liquid nitrogen of solid dispersions previously fused at
200°C markedly reduced the crystallinity of both components, as would be
expected. For 2%"/w and 10%''/w trimethoprim dispersions, no X-ray
diffraction peaks which could be attributed to the drug could be discerned,
suggesting that both the rapid cooling rate and the high viscosity of the
polymer melt had inhibited the drug's crystallisation, giving an amorphous
form. By contrast, diffraction peaks corresponding to Form I of trimetho-
prim were apparent for 5O%\V/w dispersions, albeit of a very weak intensity.
At all concentrations studied, the characteristic X-ray diffraction peaks for
PEG 4000 were present, but of reduced intensity, reflecting the decrease in
crystallinity of the polymer. DSC thermograms failed to reveal any melting
endctherrn for trimethoprim, even at 5O%"Vw, which tends to confirm the
lack of crystallinity of the drug observed by X-ray diffraction data. The
melting point of PEG 4000 was depressed by —2°C for 2%"7w and lo%w/w
quenched dispersions and to a slightly greater degree, —3°C, for 5O%"Vw
dispersions, similar to the behaviour observed for PEG 4000 alone. Again,
the crystal form present is extended chain rather than folded chain lamellae.
Reduction of the crystallinity of the polymer to — 44% was observed for both
2%'Vw and l0%'Vw dispersions, which again is of the same magnitude as
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for PEG 4000 in the absence of trimethoprlm. At the highest concentration
of drug, the slightly greater reduction in the crystallinity of PEG 4000 to
— 40% probably reflects the increased difficulty of nucleation and orientation
of polymer chains in the presence of large amounts of drug.
The effect of cooling at 8(min 1 (480°Chr 1), 60°Chf 1 and 20°Chr1
after melting at 200°C for 10 minutes on the morphology of these solid
dispersions has already been discussed in detail in the preceding sections.
Cooling rates slower than — 20Chr' led to an unacceptably high degree
of thermal degradation of the dispersions.
3.3.2.5.	 Ageing
The effect of ageing on 2, 10 and 50% w/w dispersions prepared under a
variety of conditions was investigated as for PEG 4000. Although the effect
of ageing at different temperatures on the dissolution performance of solid
dispersions has been studied by several workers (e.g. Ford and Rubinstein,
1979, 1980; Hargreaves, 1982; Khalil and Mortada, 1978), very few
investigations of the corresponding changes in their physical structure exist.
Generally, however, a deterioration in the dissolution rate is observed,
which Is usually attributed to crystal growth and conrsening of the eutectic
particles of drug with age hiou and Riegelman, 1971 ).
Dispersions containing 2% W/w and l0%'Vw trimethoprim, which had
been melted at 100°C for 10 mins and cooled at 20°Chf 1 , showed a
similar increase In the heat of fusion and crystallinity of the polymer with
time to that of PEG 4000 alone (Section 3.3.1.4.). Conversion of the
polymer folded chain crystals to the extended chain form did not appear to
be hindered by the presence of the drug as it occurred over a similar time-
scale to that of PEG 4000. No DSC transitions appeared which could be
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attributed to the melting of the trimethoprim, although X-ray diffraction
spectra showed the drug to be present in the crystalline form. There
appeared to be a slight increase in the crystallinity of these dispersions
from X-ray diffraction data, but there is no means of quantifying this
increase in terms of one or cther of the two components. Scanning electron
micrographs did n show any gross changes in structure on ageing. For
51j%W/W dispersions, the increase in crystallinity of the polymer was
slower at all storage temperatures studied than for dispersions containing
or 10%'/w drug, and was paralleled by a correspondingly slower
conversion of folded chain ]ameliae to the extended chain form • A slight
increase to —56°C was observed for the melting temperature of the extended
chain crystal type, but this is stifi less than the value for PEG 4000 alone.
Since no increase in the heat of fusion of the drug occurred (Fig. 3.20a.),
most of the trimethoprim prohably initially existed in a stable crystalline
state. As for the 2%"/w and l0%"/w dispersions, a slight decrease in the
amorphous halo of the X-ray diffraction patterns was discernible, but
scanning electron micrographs failed to reveal any significant changes in
structure. These results are in good agreement with those reported by
Hajratwala and Ho (1984) for their X-ray diffraction and SEM studies on the
ageing of 40%W/w hydrocortisone-PEG 4000 dispersions.
Very similar behaviour to that described above was observed for
dispersions which had previously been melted at 200°C for 10 minutes and
cooled at 60 0Chf', except for a few minor points. No X-ray diffraction
peaks which could be attributed to trimethoprim were apparent in the spectra
of 2%w/w dispersions, even after 6 months. Thus, at low concentrations,













Fig . 3.20. Effect of ageing at different temperatures on 50% W/,y
trimethoprim - PEG 4000 dispersions, prepared by:
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Fig. 3.20.	 c. Melting at 200°C for 10 mins and quenching In liquid
nitrogen
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though chain unfolding and lamella thickening of the PEG 4000 apparently
takes place unhindered. Dispersions containing 50%'Vw trimethoprim
showed a slight Increase in the heat of fusion of the drug after 6 months
at 45°C (Fig. 3.20b.) which may be indicative of some recrystallisatlon of
the drug. Merely increasing the size of the drug crystals in the polymer
matrix would n necessarily result in an increased enthalpy of fusion.
As for the polymer in the absence of trimethoprim, the largest changes
on ageing occurred in samples which had been quenched in liquid nitrogen
after fusing at 200°C for 10 mins. The Increase in the crystallinity of
PEG 4000 in 2%w/w and 10%W/w trimethoprim dispersions was as for the
polymer alone. No characteristic diffraction peaks for the drug could be
detected on X-ray spectra for 2%"/w dispersions at any storage temperature
investigated, even after 6 months. Weak trimethoprim diffraction lines
appeared on X-ray spectra for 10%"Vw dispersions but only after 6 months
at either 370C or 45°C. The meking point of the extended chain crystals
of PEG 4000 present rose from 55°C to 57°C as their crystalline order
increased, as has been observed previously ect1on 3.3.1.4.). AgaIn, it
seems that the polymer is able to recrystallise more readily than the drug,
which may be due in part to the nearness of the storage temperatures to
the melting point of the former, presumably facilitating molecular flexibility
and movement. X-ray diffraction peaks corresponding to the recrystallisaticn
of trimethoprim from quenched 50%'/w dispersions appeared sooner than
with lo%w/w dispersions, and were paralleled by the appearance of a DSC
melting transition. A greater degree of recrystallisation of bcth drug and
polymer occurred at the two highest storage temperatures, 37°C and 450C,
as determined by measurements of the enthalpy of melting (Fig. 3.20c.).
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However, compared to the polymer alone, recrystallisation of PEG 4000 was
slower in these dispersions.
Overall, it appears that the secondary crystallisation and lamella
thickening processes, which occur in PEG 4000 on ageing are n affected
by the presence of low concentrations of trimethoprim, and only inhibited
to a relatively minor extent even at 5O%"/w trimethoprim. Conversely
the recrysta]llsation of small amounts of amorphcus drug is hindered
within the polymer matrix, even at the higher storage temperatures.
Recrystallisatlon of trimethoprim from dispersions containing high
concentrations of drug occurs to a much g-reater extent and appears to be





Investigation of Structure by Dielectric Spectroscopy
4.1.	 Introduction
4.1.1.	 General introduction
The technique of dielectric spectroscopy has been applied successfully to
the study of the structure and properties of a wide variety of materials,
including polymers. Furthermore, it has been demonstrated that alterations
in structure arising from changes in the thermal history can be detected from
studies of dielectric behaviour for polymers such as polyoxymethylene
(McCrum et al, 1967), which is structurally re]ated to PEG. It was hoped
therefore, that the application of this technique to the study of PEG 4000 and
its solid dispersions would yield additional information about their structure
to that ottalned from DSC and X-ray diffraction. Since dielectric measure-
rnents can be performed over a range of temperature in both the liquid and
solid states, potential advantages exist over either of these methods. The
following sections of this introduction outline the theories of dielectric
behaviour and the measurement of dielectric response.
4.1.2.	 Polarlsation and polarisation mechanisms
If an external electric field (E) is applied to a dielectric, then dipoles
within the sample will attempt to align themselves in the direction of the field,
thus giving rise to a net charge on the surface of the material. This effect,
known as polarisation (1'), can be defined in terms of the charge per unit area
of the surface. Hence the response of a dielectric material to an electric
field can be expressed as the difference in polarisation produced on the plates
of a capacitor in a vacuum and in the presence of the dielectric.
- 143 -
Polarisation will be time dependent since dipole reorientation occurs at
different times and is not instantaneous. The general response for any
function which varies arbitrarily with time and which is assumed to be linear
in the field is therefore given by the time superposition principle (McCrum et
al (1967) as:
P(t) = f'	 4 (t-t) E(t') dt'	 • 4.1
where4'(t -t0) = c(t') is the response function which is defined according to
the type of electric field applied. When the field takes the form of a delta
function (Fig. 4.1.a.)
E(t') = E 0 ô(t)	
... 4.2.
where E 0 Is the amplitude of the field, then P(t) 0 at t<0 (no response
before application of field) and P(t) 0 at t-oo(no permanent polarisation
at infinite time after removal of field) and It is found that:
(t) = P(t)	 •.. 4.3.
In cther words, the response function can be expressed as the time dependency
of polarlsation following the application of a delta function field.
In the case where the field takes the form of a step function (Fig. 4.1 .b.),
defined as:
E(t') = E 0
 at t)0	 4.4.a.
E(t') = 0 at t(O	 4.4.b.
Then it can be shown that:
P(t) 
= 
f	 4(t') E 0 dt'	 ••• 4.5.
Thus	 (t) = dP(t) = J(t) defines the response function in terms of the
dt
current flow, J(t in the system. This forms the hasis of time domain
measurements for the determination of dielectric response.
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Fig. 4.1.	 Types of Electric field and response to them
Type of field applied
	 Response defined in terms of:












Thirdly, when the applied field takes an oscillating form (Fig. 4.1 .c.):
E')=E 0 exp(it')	 ...4.6.
= angular frequency
where exp( iwt) = cos(ot) - isin(wt)	 ... 4.7.
Then equation 41. becomes:
P(t) = f	 c1(t -t0) E 0 exp(iwt') dt'	 ... 4.8.




where X(co) = I	 ')exp(- it)d't	 ... 4.10Jo
X(w) is a complex function of frequency known as the dielectric
susceptibility, which can be written in terms of its real and imaginary
components as:
X(w) = X'(w) - iX"(w )	 ... 4.11.
When measurements are performed in the frequency domain, results are
usually expressed in terms of capacitance (C) and loss (G/ ). These will
be proportional to the real and imaginary parts of the susceptibility since
the capacitance, as a function of frequency C(w) can he related to X'(w)
by
C((U) = e0A {x'(w) + €(Oo)}	 •. 4.12.
Similarly, the loss as a function of frequency G(w)/w is linked to
x"(w) by the relationship:
G(w)/co	 = 0A X"(w)	 ... 4.13.
d
€ (oo) is the baseline response of the material and arises from polarisable
elements within the material which respond instantaneously at the audio and
lower frequencies used for measurement here. A is the area of the electrodes
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on the sample and d'is the distance between them, therefore E 0A is a
d'
constant for a particular experimental cell.
Molecular polarisation in a dielectric can arise from three different
components which will respond at different frequencies. These are as
follows:
(a) Electronic polarisation - where the application of an external electric
field causes a small displacement of the electrons with respect to the nucleus.
Only a small shift is seen because the applied field Is relatively weak in
comparison to the atomic field due to the nucleus. This type of polarisatiai
occurs at optical frequencies and is responsible for such effects as the
refraction of light.
(b) Atomic polarisation, here the application of an electric field can
distort the arrangement of atomic nuclei within the molecule or lattice.
As nuclei respond more slowly than electrons, this type of polarisation is
n seen above infra-red frequencies.
(c) Orlentational polarisation, if molecules possess permanent dipole
moments, that is where the centres of gravity of the positive and negative
charges do not coincide, then there is tendency for these to align within an
applied electric field to give a net polarisation in that direction. For molecules
with no permanent dipole moment, an induced net moment will be seen as
the result of separation of centres of gravity of positive and negative charges.
Orientational polarisation is seen at frequencies below those of the infra-red
hand.
A plot of molar polarisatlon as a function of frequency (Fig. 4.2.) will
show that as frequency increases, there is a characteristic stepwise fall in
polarisation as successive components become unable to relax quickly enough
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Fig. 4.2.	 Dispersicii of molar polarisation in a dielectric
From Blythe (1979)
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to contribute to the response. Elements which give rise to the electronic
and atomic polarisation wifi respond instantaneously at the audio and lower
frequencies used for measurements here and hence will only be observed as
the baseline response, E(0O).
4.1.3. Debye Theory of Relaxation
Debye (1912, 1945) examined the dynamics of the response of a charged
dipole embedded in a viscous medium and proposed a general model for all
types of relaxation behaviour, whether it be acoustic, magnetic, dielectric
or mechanical. His model is based on a physical approach which assumes
dipole elements to be non-interacting, thus Boltzmann's superposition
principle wifi apply. This states that the total magnitude of the susceptibility
wifi be given by the sum of the responses and each exhibits an identical
relaxation time. Approach to equilibrium will be exponential, therefore the




r is the characteristic Debye relaxation time for the polarisation process
and is related to the viscosity of the medium. It is often an activated function
of temperature.
r(r) =	 rexp(/kT)	 ... 4.15.
Equation 4.14. has as its solution the decay function:
P(t) = P0 exp(-t/r)	 • 4.16.
or P(t) = X(o)E exp(-t/T )	 . 4.17.
Where X (o) is the magnitude of the real part of the susceptibility at zero
frequency.
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Equation 4.15. gives the response function 4) (t) as:
4) (t) = x (o)	 -1 exp (—t/T )	 ... 4.18.
Thus the corresponding frequency domain susceptibility function is:
X(w) = X(o) -1 f 00 exp(- iwt)exp(-t/r ) dt	 ... 4.19.
Which is equivalent to
= X(o) 1	 1	
-	
(,)T	 ... 4.20.
11+w 2 r 2	 1+w2 r25
If X(w) is written in terms of its real and imaginary components X'(w)
and x"() as in equation 4.11., then:






The complex nature of the susceptibility function X (w) reflects the delay
of the response of the exponential time decay seen in Equation 4.16. Thus
the Debye response can be characterised by two parameters, namely, the
magnitude of the susceptibility, X (o) and the relaxation time, T
If X'(cv) and X"(w) are plctted as a function of frequency on a log-log
scale, then the characteristic Debye dispersion curves in Fig. 4.3. are
obtained. On this presentation, the dielectric loss curve X "(u') is
symmetrical about wp, with a slope of +1 or -1 on both sides and a half
height width of 1.144 decades. The maximum loss value occurs when
(s) T = 1 and corresponds to a loss peak frequency of uip = l/T . At
frequencies lower than up, X '(u) becomes constant with a limiting value









4.1.4.	 Qther susceptthility presentations
Experimentally, Debye's model is found to apply only to systems such as
weak concentrations of gases, where the conditions assumed by this theory,
i.e. independently relaxing dipoles, hold true. Liquids and solids will
always show deviations from the Debye response, since the particle-particle
Interactions present play an important role in relaxation. In real systems,
the dielectric loss peak brondens to give a half height width much greater
than the 1.144 decades seen in the Debye response. Furthermore, the loss
peak maxima are lower than predicted and the loss curve may be asymmetrical.
This led Cole and Cole (1941) to propose a semi-empirical model to
descrthe the observed behaviour, where they presented the data as a pict of
X"(co) as a function of X'(o). For Debye's theory, this presentation
gives a semi-circle passing from the origin in the complex susceptibility
plane, diameter X(o), and with its centre lying on the real axis of suscepti-
bility (Fig. 4.4.).
The empirical relationship proposed by Cole and Cole to explain dielectric
relaxation in polymers was of the form:
X(w) = X(0)	 1	 ... 4.23.
+ (jw/wp)l' }
a' was limited to values between 0 and 1 and was an experimental constant
for the material under investigation. It was suggested that there was a range
of relaxation times with a symmetrical distribution about r. The empirical
shape parameter, a' , was introduced because it was realised that the two
parameters of the Debye model were too restrictive to describe the experi-
mental situation. When a' 0, the Debye response is recovered, but as













Fig. 4.5.	 Cole-Cole presentation when a') 0
A O)
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(Fig. 4.5.). This corresponds to the half width of the loss peak broadening
and the loss peak maximum decreasing on the Debye dispersion curves.
However, the power law behaviour, as seen in EquatIons 4.21. and 4.22.,
is stifi retained at the high and low frequency limits with respect to p.
This proposed spread of relaxation times was seen as a likely explanation of
the broadness of the relaxation in systems which consisted of long chain,
tangled molecules, where a wide range of forces inhibiting the independent
reorientation of dipole elements could be expected.
Davidson and Cole (1951) proposed a slightly different relationship,
(Fig. 4.6.), where the distribution of relaxation times about r is assumed
to be skewed.
X(w) = X(0)	 1	 ... 4.24.
(1+ iw/wpii3'
Again, ' is a parameter between 0 and 1 and is constant for the material
under investigation, the Debye response being obtained when $' = 1.
Although no physical explanation of this relationship was proposed, It does
provide a good fit to some sets of experimental data.
More recently, Cook, Watt and Williams (1970) suggested that the approach
to equilibrium may not in fact be exponential as assumed by Debye, and that
this could lead to the observed breadth of dispersion in polymers. A decay
function was proposed as follows:
'I'(t) = exp(-t/T )Y
	
4.25.
Where Y' is a parameter between 0 and 1. This again shows good agreement
with some sets of experimental data, but no physical explanation has yet
been established.
However, some experimental results were found not to fit any of the
single parameter empirical models proposed above. This led Havriiak and
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Negami (1966) to propose the first bi-parametric susceptibility function, in
order to fit data which tails off at the high and low frequency limits on a
Cole-Cole plot (Fig. 4.7.).
X(w) = X(0)	 1	 ... 4.26.
[1 + ( iw
Where 0< a'< 1
13'< (1 - a' )1
Recently, Jonscher (1977) observed power law behaviour in a large number
of materials in bcth the real and imaginary parts of the susceptibility function
at frequencies higher than wp, which are interrelated by the expression:
X'(c') = x"(w)tan (nir/2)	 wT1'	 •.. 4.27.
Where 0<n1
This relationship, known as the universal law of dielectric response, states
that the ratio of energy lost per cycle to that stored per cycle is constant.
Thus cii a Cole-Cole presentation, this corresponds to a straight line on the
high frequency side (Fig. 4.8.). The universal law can be derived from
current many body theory, as will be shown later.
Hill (1978) proposed a more general empirical susceptibility formula
which will give power law behaviour at frequencies below as well as above
the loss peak frequency.
m
X(w)	 cL	 ... 4.28.
(W 2 + 2s) 1 4 -
Where 1 < n, m, s <0
The constant, s, is only significant where w	 Wp.
It is important to remember that all the presentations described above,
except Debye's, are empirical mathematical formulae which have no physical




Fig. 4.7.	 Cole-Cole pic showing tailing behaviour at high and low
frequency limits
X(cii)




4.1.5. Dissado-Hil theory of dielectric response
This theory, 1sed on the concept of a many body co-operative model is
capable of giving a complete description of dielectric susceptibility.
Furthermore, both Hill's empirical relationship and Jonscher's universal
Jaw of dielectric response can be derived mathematically from it.
Since particle-particle Interactions are always present in solids and
liquids, Dissado and Hill (1979) consider a system which consists of coupled
particle displacement motions. As a consequence of this, relaxation of any
particle must necessarily modify a group of others and thus Its environment.
This is In contrast to the Debye model which postulates independently relaxing
dipoles. Moreover, it is assumed that the system has locally correlated
motion up to some finite extent. The spatial extent of these local vibrational
modes can be defined as a cluster. Not all clusters are identical, giving rise
to a dynamic distribution of cluster types. Hence, over a period of time, each
cluster will adopt all the possibilities allowed within the cluster system.
This Is not equivalent to the distribution of relaxation times proposed by Cole
and Cole (1941) as an explanation for non-Debye behaviour. These authors
stated that although the environments of the particles were different, they
were not modified during relaxation, I.e. there was a static distribution of
environments.
Dissado and Hill (1979) noted that correlated motions In clustering systems,
such as ferromagnetics, are known theoretically to give t fl behaviour for
the relaxation of dipole displacements. Secondly, they noted that the origin
of the fractional power law behaviour lay in the time development of the
probability of finding the particles of the cluster at their original displacements.
These concepts have been developed by Dissado and Hill to form the basis of
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their general model for relaxation. It should be remembered that this
theory does n only apply to dielectric phenomena, but can also be used to
explain cther types of relaxation behaviour, e.g. mechanical.
The formal re]axation function of the cluster is proposed to be issado
and Hill, 1979, 1983):
Wp exp(- wpt)t	 1 F1 (1 - m; 2 - n; (i)pt) ... 4.29.
with 1 F1 ( ; ; ) the confluent hypergeometric function (Slater, 1960).
This gives the susceptibility as:
X(ui)	 J	 ()p	 1 - n 2F1 (1 - n, 1 - m; 2 - n; 	 Wp)
(L)p+iW	 J	 (Vp+iCL)
4.30.
with 2F1 ( , ; ; ) the Gaussian hypergeometric function (Slater, 1966).
Equation 4.28. showsthat atfrequencieshigherthanwp, bh the real
and imaginary parts of the susceptibility are proportional to (,) T1 , which
is identical to the relationship proposed by Jonscher (1977) and Hill (1978).
At frequencies lower than Wp, the imaginary part of the susceptibility
function is proportional to C m and the real part to X'(0) - A' X"(w),
where A'is a constant. This again is in agreement with Hill's (1978)
empirical relationship.
Jonscher (1978) has also identified a new type of response found in dipolar
systems formed from charge carriers, which may move from their original
clusters or sites. The polarisation response, due to charge separation over
substantial distances, seen in these systems has been termed low frequency
dispersion (L.F.D.) and its susceptibility function can be defined as (Dissado
and Hill, 1984a)
XL-(W) = NS (kc 2 ri - p-n)	 F (w/o.)	 ... 4.31.
kT	 F(1-n)F(1-p)
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Where N is the number density of occupied sites and F(c&,/w is the
dielectric shape function equivalent to:
(S,) ....	 1.1 - n 2 F1 (1 - n, 1 +p; 2-n;	 )	 ... 4.32.
'	 wc+ic)
The Dissado-Hil theory can be outlined as follows:
(1) MaterIals that exhibit dielectric relaxation will contain structural
Imperfections and thus, on a localised scale, the existence of groups of
dipoles (clusters) can be expected.
(2) The motion of any particular cluster can be organised into a hierarchy
of sub-units which are arranged according to the number of irreducible
dipole elements they contain. Also, the motion of each of the sub-units takes
place in the rigid environment of all other elements of the cluster. Each
dipole element is involved in a fraction of all possible sub-unit motions.
These range from the element behaving as an independent dipole, up to the
whole cluster as a rigid body. From these considerations, Dissado and Hifi
(1979) have calculated that the probability of finding a dipole element in its
original displacement Is t, where the parameter n lies between 0 and 1
and indexes the extent to which dipole displacements are correlated.
Alternatively, It Is possible to define n in terms of the degree to which the
structural organisation of a sub-unit is reproduced by increasing its size to
a sub-unit of larger number, i.e. a scaling index. In practice, n will
always be less than unity because the dipole elements constituting the cluster
do not have full translational symmetry.
Recently, Dissado (1984) has related the process giving rise to the t
behaviour to the change in configurational entropy of the cluster as a
specified configuration relaxes. This provides a link between the Dissado-
Hill theory and the thermodynamics of relaxation, thus emphasizing the
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relationship of the result to environmental changes during relaxation.
(3) Cluster fragmentation and conlescence is allowed by Dissado-Hill
theory as follows. Correlation of sub-unit motions with those of other
clusters in the cluster array can take place, usually in a different co-ordinate
to that of the local cluster. This produces a description of the cluster
ensemble in terms of a dynamically fluctuating system, with an instantaneous
distribution of cluster types. The long time decay,	 a + m) Is due to the
influence of these fluctuations on the random thermal contributions to the
cluster relaxation. The index m ( p) is a measure of the degree to which
clusters interact, i.e • a measure of the extent and correlation of transfer
processes between clusters. This index defines the shape of the distribution,
(Fig. 4.9.).
It can be seen that the case of m = 0 refers to the case where all clusters
are identical and that the distribution changes continuously from this delta
function to the case of m = 1, which Is exponential over the range 0 < y < 00.
These distributions describe the fluctuations that arise from inter-cluster
transfers.
Dissado and Hill (1984b) have recently shown that the recovery of the
dynamic steady state distribution during relaxation can be described by the
evolution of an array configurational entropy, at the expense of individual
cluster configurational entropies during the relaxation phase in which excess
energy is returned to the heat bath. In this way, the thermodynamic causes
of relaxation can be seen to determine the experimentally observed relaxation
behaviour.
Thus the Dissado-Hill theory as outlined above offers a new and fundamental








Distribution of fluctuations for the parameter mCp)
(Hill et al, 1981)
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y
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therefore be used to interpret the experimental data obtained from the work
on PEG 4000 and its solid dispersions with Trimethoprim.
4.1.6. Dielectric relaxation in polymers
Several discrete relaxation processes, which arise from the different
types of molecular motion, can often be distinguished in polymers in the
solid state • A scan of dielectric loss at constant frequency with increasing
temperature often reveals several loss processes. These are associated
with the different molecular mobiities becoming energetically favourable,
hence enabling dipole elements to reorientate and contribute to the dielectric
response. By convention, dielectric relaxation processes are arbitrarily
labelled as c, j3 , , etc., starting from the high temperature end
(Fig. 4.10.). On a frequency scan, this Is equivalent to starting at the
low frequency limit and working upwards in frequency.
Different relaxation processes will be associated with the amorphous and
crystalline regions of the polymer and either one or both types may be
present. The symbols a, /3 ,y are usedtodescribeprocessesinboth
regions, but it should be remembered that this does not imply that the same
molecular mechanisms are responsible in each case. The same relaxation
processes are generally thought to be occurring in both the dielectric and
mechanical dispersions observed in polymers, but the relative magnitudes
of the response may be different. Thus, in a semi-crystalline polymer such
as PEG 4000, the relaxation spectrum may be complex. In order to aid
Identification of the phase from which any relaxation process arises, the
physical structure of the polymer can be altered by, for example, varying
the rate of cooling from the melt. If polytetrafluoroethylene (FT FE) Is















relaxation (Fig. 4.11.). The magnitude of this process is enhanced by
annealing as the degree of crystallinity increases, whereas quenching the
material to the amorphous form will decrease the magnitude of the response.
Conversely, for relaxation processes arising from molecular mions within -
the amorphous phase, annealing the material would have decreased and
quenching increased the observed response.
In the liquid state, the polymer will exist as randomly orientated, tangled
chains with a high degree of molecular mobility. However, there will be little
coordinated molecular mion.
4.1.7.	 Dielectric relaxation in a solid dispersion
The effect of adding a second component, such as a drug, to the polymer
is difficult to predict and is complicated by the fact that the drug may exhthit
a separate dielectric response. Thus three possibilities exist - the relaxation
processes associated with either material may be enhanced, Inhibited or
unaffected by the presence of the other component. This would depend largely
on the configuration and orientation adopted by the two components relative
to each ct.her as well as on their chemical structure. It is envisaged that
the degree to which the response is affected could well be dependent on the









Fig. 4.11.	 Temperature dependence of dielectric loss tangent at iO Hz
in the are1axation region for three samples of polytetra-






	 •	 I	 •	 I \




Quenched sample - most amorphous
0 Annealed sample - most crystalline
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42.	 Methods
4.2.1.	 DielectrIc Measuring System
4.2.1.1.	 Dielectric cell and temperature control
The work here was performed using a dielectric cell consisting of two
nominally plane and parallel stainless steel electrodes mounted in a copper
jacket, (Fig. 4.12.), which is a design that previous studies (Shablakh,
1982) have shown to be optimal for this type of system. This cell was
positioned on a copper heating block from which it was electrically
insulated by a thin mica sheet. The temperature was controlled by a
platinum resistor temperature sensor mounted In the heating block and a
Eurntherm controller connected to a specially designed Servo power supply;
a method which has been shown to be accurate to better than + or -0.5°C,
hablakh et al, 1982). The dielectric cell, heater and leads were placed
inside an Edwards high vacuum system and evacuated to 10_i Torr. This
degree of vacuum was found to be adequate to avoid water vapour condensing
on the leads at low temperatures. The sample, however, remained at
atmospheric pressure within the cell.
4.2.1.2. Frequency Domain Measurements
A computer controlled frequency response analyser (F.R.A.) was used
which measures the voltage across and current flowing through a dielectric
sample in response to an applied a .c. field, over a frequency range from
1O4 to l0 Hz. Loss angle (tan ô) resolution is better than i(i for most
practical applications (Morse, 1974). A schematic diagram of the system
and peripheral instruments is given in Fig. 4.13. A variety of software
was available and the programmes used will be discussed later. The results
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Fig. 4.13. Diagram of computer controlled frequency response analyser
and peripheral instruments
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obtained were recorded on tape, as a print-out and plotted on an X-Y recorder.
4.2.1.3.	 Principle of Operation of the F.R.A.
The F.R.A. consists of two main parts - a generator and a correlator.
Sine waves of a previously programmed amplitude are produced by the
generator using one of two methods according to the region of frequency in
which it Is operating. Above 150 Hz, smooth sine waves are produced by
conventional techniques. Below this frequency, waveforms are synthesized
digitally, giving a sine wave signal consisting of 2000 staircase steps per
cycle. Smoothing of step edges, which would otherwise degrade the signal,
is effected by means of a low pass filter, positioned at a suitable point in
the measuring circuit. The signal is then applied across the dielectric
sample, In series with a suitable resistor/capacitor combination, which is
selected automatically by the measuring box as that which gives the most
effective standard impedance for that sample and frequency. The correlator
then determines the in phase and quadrature components of the input signal
with respect to a reference signal produced by the generator. Following
this, the results are processed by the computer and recorded as required.
4.2.2. Types of experiments
The following methods were used to study the dielectric response of
PEG 4000, trimethoprim and systems containing various proportions of
both.
(i)	 Frequency scans - Capacitance and loss were measured over a
range of frequency at intervals in temperature of 10K from 363K to 223K
for both heating and cooling cycles. All samples containing PEG 4000, both
with and without the drug were heated at 363K for 1 hour prior to
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measurement to ensure complete randomisation of polymer chains and thus
remove any possible influence of thermal history.
(ii)	 Capacitance as a function of time - At a previously selected frequency
and temperature, changes in capacitance were recorded against time. This
type of scan was used to study the time dependence of the phase changes,
either melting or crystallisation, of PEG 4000 on Its own and in the presence
of the various concentrations of trimethoprim.
4.2.3.	 Circuit analysis of the response
The thta obtained can be presented as a dielectric circuit response for
each temperature. A dielectrically active circuit can be described in terms
of a dispersive process, a parallel "infinite frequency" capacitance and a
parallel resistance or conductance, (Fig. 4.14.). The dispersive element can
be characterised by four parameters:
(i)	 The characteristic frequency, Wp, which is the relaxation rate for
the process being observed.
(ii) The zero frequency susceptibility magnitude, C (0)' which is a
measure of the strength or number of responding elements.
(iii) Two Dissado-Hill spectral shape parameters, n and m, where n
indexes the degree of local structural order and m the efficiency of the
interciuster exchange process.
A computer curve fit procedure is used to obtain the magnitude of each
of the individual elements.
Since the measurement of dielectric response requires electrcxJes to be
positioned on the sample, in this lnstanc& on opposite faces, then it is
necessary to consider two such elements in series with each other. This
allows for the effect of the contacts on the sample, e.g. there may not be
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Fig. 4.14.	 Typical dielectric circuit
1	 Frequency dependent or dispersive capacitance
2	 Frequency independent or infinite frequency capacitance
3	 Resistance ( 1/conductance)
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a perfect exchange of charge between the electrodes and the material. The
sample is assumed to have a bulk response, associated with the bulk of the
material, and a surface response associated with the two regions In the
proximity of the electrodes. The response of each of the surface elements
is assumed to be equivalent in the presence of an a.c. field.
Dielectric circuit analysis allows complete characterisation of the
response In terms of the parameters discussed above, which can then be
interpreted in terms of their physical basis to give useful Informaticn on
the structure of the material under investigation.
43.	 Results and discussion
4.3.1.	 PEG 4000
4.3.1.1.	 PEG 4000 liquid
Since the dimensions of the experimental cell cannot be measured as
accurately as the dielectric response, the results are presented in terms of
capacitance ) and loss (G/w) which, apart from geometric scaling factors,
are Identical to the real and imaginary parts of the susceptibility function
X(o). Where possible, the dielectric measurements are subjected to a
normalisaticxi technique (Ferry, 1 970; Hill, 1978 ) in which the sets of
results obtained from the frequency scans at different temperatures are
rescaled in frequency and amplitude to produce a master response curve.
Normalisation of the results is only possible where the different components
which give rise to the overall response exhibit the same temperature
dependence with respect to each other. If a datum point is recorded from
the frequency scan at each temperature, then the relative shift of the response
with each temperature can be observed and used to determine the temperature
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dependence of the characteristic frequency arid amplitude.
Frequency scans of PEG 4000 equilibrated at 363K gave a response which
characterised the liquid state. Values of capacitance and loss bch rise with
decreasing frequency and the behaviour of the liquid appears to be dominated
by a R-C circuit combination at low frequencies, while towards the high
frequency end, the capacitance tails off to a limiting value. This behaviour
persisted down to temperatures of 323K, as can be seen from the composite
graph in Fig. 4.15. Normalisation of the data from the liquid phase proved
difficult as the components of the frequency response showed different shifts
relative to each cther as the temperature changed.
From dielectric circuit analysis, it was found that the data could be
modelled in terms of the circuit diagram given (Fig. 4.15.) that is by:
(i) A frequency dependent barrier of surface capacitance (C s) in series
with
(ii) A frequency independent capacitance (C) and
(iii) A conductance (Gb) which arises from a d.c. charge transport
process. Bth (ii) and (iii) were associated with the bulk response.
The values of the individual characteristic parameters at different
temperatures are given in Table 4.1. and were obtained by the curve fitting
procedure outlined in Chapter 4.2.3.
From the circuit analysis it can be seen that there are two components
to the dielectric response - one associated with the bulk and one associated
with the region adjoining the electrodes. The bulk response is domirted
by a high conductance arising from a d.c. charge transport process which
is unusual in saturated organic polymers of this type, being approximately


















/ + 343 )C















-1	 0	 1	 2	 3	 4	 5
Log frequency (Hz)
- 174 -











•1	 —	 N	 0	 0	 0	 0








E	 S	 U	 U	 U
4)
'-I
CV)	 CV)	 CV)	 CV)	 CV)
CV)	 if)
C-	 CV)	 CV)	 CV)	 C)	 CV)
4)
- 175 -
(Binks and Sharples, 1968). Conductances of this magnitude are usually only
observed in more complex polymeric structures such as those which contain
double bonds,where electronic conduction processes can occur through
overlapping r orbitals. It has, however, been established (Binks and
Sharples, 1968) that this high conductance is n due to the presence of
sorbed water or any icncgenic impurities which might be left from the
polymerisation process and is thus an inherent property of the material.
The temperature dependence of the bulk conductance was determined
by constructing an Arrhenius pl from the data at different temperatures
(Fig. 4.16), excluding that obtained at 323K, since the graph becomes non-
linear as the crystallisatlon temperature is approached. From this, the
activation energy of the process was calculated to be 0.106 eV. In the molten
state, the polymer chains possess considerable flexibility and mobility and
have no preferred direction of orientation (Maxfield and Shepherd, 1975).
The decrease In the conductance with decreasing temperature indicates that
the d.c. charge transport process from which it arises becomes more
difficult as the temperature is lowered. This is consistent with the polymer
chains becoming less mobile as the crystallisation temperature is approached.
The activation energy of 0.106 eV corresponds to a wavelength of approximately
851 P cm 1 . No absorption at this wavelength is seen for polyethylene glycol
in the molten state when investigated by Raman spectroscopy (Koenig and
Angood, 1970). However, I.R. spectroscopy reveals a band at 855 p cm,
which corresponds to a CH 2 rocking movement and a C-O bond stretch
(Matsuura and Miyazawa, 1969). Molecular mthon observed at this
frequency thus involves a change in dipole moment and is therefore likely








It has been suggested that the conductance may occur through one of two
possible mechanisms. NMR spectroscopy has revealed that one relaxation
route occurs via the flip-flop process in Fig. 4.17. (Kimmich and Schmauder,
1977) requiring an activation energy of 0.113 eV, similar to that calculated
here. This movement would allow transport of charge through the system by
the interaction of oxygen atoms along the polymer chain and correlates well
with the suggested Involvement of the molecular mcticn observed by L.R.
spectroscopy. Alternatively, charge may pass through the system by the
mechanism of inherent proton generation proposed by Binks and Sharples
(1968). They suggested that protons are removed from the polymer chains
and transported via the ether oxygen atoms through local segmental motions
such as molecular rotations. Again, it is very likely that this mechanism
would involve the CH 2 rocking and C-O stretching movements implicated by
I.R. data. The proposed transport mechanism for protons is illustrated in
Fig. 4 • 1 8a. and that for the negative charge In Fig. 4.1 8b.
The behaviour of the polymer in the region adjoining the electrodes differs
from that observed for the bulk material, in that It is a non-conducting layer
which only allows a slow dielectric relaxation. Arrhenius plots constructed
for the loss peak frequency (Fig. 4.19.) and loss peak magnitude (Fig. 4.20.)
of the barrier response gave activation energies of -0.683 and 0.800 eV
respectively. The temperature dependence of the loss peak frequency is
unusual in that the relaxation rate appears to increase as the temperature
decreases. The apparent activation energy of the loss peak frequency
( iw,) of the barrier relaxation can be related to the activation energies of














Fig, 4.17.	 Relaxation rcute from which the charge transport process in
molten PEG 4000 could arise (Kimmich and Schmauder, 1977)
C C 0 C g/O\(C\/C\
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g,	 are positive and negative gauche conformations
Fig. 4.l8a. Ionic prcton transport mechanism from which charge transport












































p=	 G	 ... 4.33.
= 0.106 - 0.800
= -0.693 eV
which is very close to the value of -0.683 eV observed for
	 Wp. This
interrelationship between the magnitude and relaxation rate of barrier shows
that the process attributed to the barrier is not that of a reorientating dipole,
but rather a region of charge diffusion. This is in spite of the fact that Its
frequency dependence (0.7) is not that expected classically ç0.5)
(de Gennes, 1982). However, it has been noted that segmental diffusion In
polymer melts gives this form of behaviour (Klymko and Kopelman, 1983).
Charge transport through a partially disordered matrix also gives the same
frequency dependence (Shapiro and Abrahams, 1981).
Thus it appears that the behaviour of the polymer at the barrier is
consistent with a restricted movement of charged segments or kinks of the
polymer chain which are adsorbed onto the electrode. In the bulk of the
liquid, conduction can occur through the d.c. transport process observed
because of the freedom of movement of the polymer chains, allowing the
possibility of molecular transport of the charge. However, In the barrier,
molecular motion is restricted because parts of the molecule are presumably
"tied" to the surface of the electrode. Charge transfer is therefore forced
to occur via transfer of the chain distortion through the chain itself. This
motion is obviously more difficult since the activation energies associated
with the barrier response are higher than that calculated for the bulk
conductance.
The barrier layer can therefore be visualised as a single layer of
PEG 4000 molecules adsorbed onto the surface of the electrode via the
- 181 -

























ether oxygens of the polymer chain (Fig. 4.21 .). The magnitude of the
barrier capacitance supports this contention since a rough estimate of the
barrier thickness Is of the order of 0.5 nm, approximately equivalent to
the cross-sectional diameter of one polymer molecule.
4.3.1.2.	 PEG 4000 solid state
Samples equilibrated below the melting point of the material showed
responses typical of the solid, which could be normalised over the temperature
range investigated. It Is important to ne that the solid and liquid dielectric
responses are very different and do nct normalise tcgether. Results obtained
during the cooling and heating cycles (Fig. 4.22a. and b. respectively) were
essentially similar apart from some hysteresis, seen as a shift to lower
frequencies on the heating curve. On cooling, a maximum was observed in
the loss at around io Hz at 313K which was absent during the heating cycle.
Circuit analysis (Fig. 4.22.) revealed that the barrier layer present in
the liquid was retained intact on solidification with minimum modification to
its structure, although presumably molecular exchange with the bulk was now
prevented. Estimates of the thickness of this layer at about 0.5 nm on each
electrode corresponded to those obtained in the liquid are therefore
consistent with the structure proposed in 4.3.1.1. The similarity of the
Dissado-Hill parameter, n for the barrier in the solid and liquid provided
further evidence for this view.
A new element Is introduced into the bulk response as a result of
crystallisatlon, seen as a frequency dependent capacitance. In addition, a
conductance arising from a d.c. charge transport process was present, as
in the liquid. The other frequency dependent capacitance is common to bcch
bulk and barrier responses and thus behaves as a parallel circuit element.
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Fig. 4.22b.	 0n heating cycle
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Scaling of the magnitude of the Individual components at different temperatures
was carried out by the usual curve fitting procedure and the results are
given in Tables 4.2. and 4.3. for cooling and heating cycles respectively.
The Dissado-Hill shape parameters remained constant throughout the
heating and cooling cycles for both bulk and lrrier responses. From the
values of m = 0.4 and n = 0.45 for the dispersion in the bulk, it can be
concluded that the system contains a fairly wide range of constructions but
there is some degree of local correlated motion.
On the cooling cycle, no temperature dependence was observed in the
amplitudes of the loss processes (C (0)1 and C (0)2), which is in contrast
to the behaviour on heating where these values remain constant only up to
318K and then become temperature dependent. Arrhenius plots of the loss
peak frequencies, Wpj and Wp and the conductance arising from the d.c.
transport process, G02, were constructed for both heating and cooling data
(Fig. 4.23. and 4.24. respectively). Very similar activation energies of
around 1.1 eV were determined for these parameters. In all cases, data
obtained above 318K on the heating curve did not lie on the straight line
formed by the lower temperature data and hence were not used to calculate
activation energies.
Since the loss peak frequency in both bulk and harrier responses and the
conductance during heating (up to 318K) and cooling cycles all show the same
temperature dependence, it can be assumed that the same molecular relaxation
route governs all these elements. Furthermore, this relaxation must be
associated with the crystalline lamella of the polymer because the Arrhenius
plots obtained are linear and thus do not show the characteristic behaviour
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Fig. 4.23.	 Arrhenius plots for bulk and barrier loss peak frequencies
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Fig. 4.24. Arrhenius plots for bulk conductance on heating and cooling
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gradient would be expected as the temperature is lowered, giving a curve
(Blythe, 1979). Decossas et al (1982), who carried out dielectric measure-
ments from 77 -400 K at various frequencies between 500 and 106 Hz, report
evidence for a high temperature C c relaxation associated with the crystalline
region. They found that this process, observed as a shoulder on the loss
curve as here, was difficult to investigate fully because of the strong
conductivity also associated with the response at high temperatures, thus
preventing any calculations of the activation energy involved. In this work
however, circuit analysis of the dielectric response has allowed full
characterisation of the individual components. Investigation by DSC and ESR
(Lang et al, 1 977a, 1 977b) again reveals the presence of a high temperature
ac relaxation region below the melting point. From the ESR data, the
activation energy was estimated as approximately 2.19 eV (equivalent to
50 Kcal mol& 1) although the authors suggest that their sample began to melt
in this region. NMR spectroscopy (Hikichi and Furuichi, 1965) of a sample
of PEG 4000 shows that rapid narrowing of the brond component occurred
between 270K and the melting point, which was assigned as arising from an
a c crystal disordering mechanism. From these results and from measure-
ments of dielectric response performed over a very limited range of frequency,
the authors concluded that molecules in the crystalline regions must move
without destruction of their helical structure, involving rotational or oscillatory
movements around the helical axis. However, this assumption is based on the
fact that they observe no dispersion in the dielectric response over the
temperature range in which the NMR line width narrows, indicating that
dipole reorientation was not involved in the molecular motion seen. Closer
examination of their dielectric data, however, reveals that a small dispersion
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is in fact present and hence dipole mctlon is involved in the relaxation,
as is found in this present work and that of Decossas et al (1982). Hikichi
and Furuichi (1965) give a rough estimate of the activation energy of the
process as 1 .73 eV (40Kcal mole 1 ), which is of the same order as that
calculated here.
The ac relaxation probably occurs mainly on the surface of the lamelia,
Involving bcAh the chain ends of the molecules which are excluded from the
crystal and the chain folds. Some whole chain mion may be present,
leading to distortion of the lamella itself. This is in agreement with the
NMR data of Hikichi and Furuichi (1965) which shows that the temperature
at which the brond component narrows is not dependent on molecular weight
In the range they studied (PEG 1000-PEG 4000) suggesting that only a small
proportion of the molecule is involved. The d.c. charge transport process
giving rise to the conductance could also arise from this mechanism.
From 318-328 K in the heating cycle, there is a discontinuous increase
in the conductance and capacitance values obtained from circuit analysis
such that they do nct fit with the rest of the results. However, this is not
due to the material melting since frequency scans of the response still
normalise with lower temperatures and correspond to that of the solid phase.
The sample of PEG 4000 investigated here had been crystaflised under
non-isothermal conditions before being heated, which will give rise to both
extended and folded chain crystal forms, (Kovacs et al, 1977). Frequency
scans were then performed at discrete temperature intervals in the heating
cycle, this stepwise increase in temperature is equivalent to successive
heat treatments (Lang et al, 1977b). Therefore, the thermodynamically less
stable material (i.e. that which previously crystallised as once folded chain
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crystals) will begin to melt as the temperature Is raised and will subsequently
recrystallise as the more thermodynamically stable extended chain crystal
form with a higher melting point (Point and Kovacs, 1980). DSC results and
direct microscopic observation suggest that this chain unfolding dons not
involve large scale melting followed by recrystallisation,but rather that the
two processes occur simultaneously (Buckley and Kovacs, 1976).
It is expected that the same relaxation route via the chain ends located on
the surface of the lamelia would be possthle whether extended or folded chain
crystals or a mixture of the two species were present. This is borne out by
the fact that frequency scans performed at 323K and 328K normalise with
those obtained at lower temperatures. However Decossas et al (1982) noted
that chain folding will reduce the number of chain ends which are found on the
surface of the Iamel]a in any given area, thus the extended chain form will
possess the highest density of chain ends on the surface. There is also good
evidence that hydrogen bonding occurs where the concentration of hydroxyl
groups on the surface of the lamella is sufficiently high (Buckley and Kovacs,
1976). Both of these suggest that the extended chain crystal form supports
faster relaxation and charge transport rates than the folded ctain crystal
lameUae, which is consistent with the sharp increase in frequency factors
seen above 318K on the Arrhenius plots in Figs. 4.23. and 4.24.
As previously mentioned, the heating and cooling curves exhthit hysteresis
with respect to each other which can be shown more clearly if a graph of
capacitance as a function of temperature at fixed frequency is constructed
(Fig. 4.25.). Temperature lag effects were eliminated as an explanation
of this phenomenon, since examination of the response at two different









Fig. 4.25.	 Capacitance as a function of temperature cycling at fixed
frequency (10 Hz) of PEG 4000
230 240 250 260 270 280 290 300 310 320 330 340 350 360
Temperature (K)
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On cooling, the phase transition from liquid to solid, seen as a sharp drop
in capacitance at 10 Hz, occurred between 318 and 313K. This was followed
by a steady decrease in the capacitance which tailed off towards a limiting
value at low temperatures. The heating curve ran almost parallel to but
did nct coincide with the cooling curve and the rise in capacitance associated
with the return to the liquid state occurred between 328 and 333K. This is
consistent with the data obtained by DSC (Chapter 3.3.1.) where the melting
point of extended chain crystals of PEG 4000 was found to be 330K. Therefore
a significant degree of supercooling of the liquid below the melting point
occurred, even at relatively slow cooling rates. This is a common feature
of polymer melts (Sharples, 1966) and reflects the finite time required for
the nucleaticn and growth of crystals. The polymer exhibited an increased
capacitance on first forming the liquid state and to clarify this behaviour,
a further investigation of the melting and crystallisation transitions of
PEG 4000 was carried out as detailed in the following two sections, (Chapter
4.3.1.3. and 4.3.1.4.).
The effect of different thermal treatments on the dielectric response of
PEG 4000 in the solid state was also investigated. Quenching of the material
by solidification in liquid nitrogen was carried out to produce a more amorphous
form of the polymer. Previous experiments (Chapter 3.3.1.) however, had
shown that it was extremely difficult to remove all crystallinity and produce
a totally amorphous material. A frequency scan at 293K showed that this
treatment enhanced the magnitude of the low temperature dispersive process
and reduced the	 c response compared with material which had been cooled
at the normal slower rate (Fig. 4.26.). Since the low temperature process










Fig. 4.26.	 Effect of quenching on frequency response of PEG 4000 at 293K
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of the main chains in the amorphous region onnor et al, 1964), these
results demonstrate a decrease in the crystallinity. Annealing of PEG 4000
was achieved by cycling the sample between 333K, just above its melting
point and the solid at 293K. A frequency scan of the polymer at 293K after
the first cooling and heating cycle showed the response typical of that
normally observed at this temperature. However, after the third temperature
cycle, the dielectric behaviour of the sample (at 293K) was similar to that
which would be expected at higher temperatures such as 323K (Fig. 4.27.),
indicating that a shift in the frequency response to higher frequencies had
occurred. As a consequence of the rapid heating and cooling cycles, only
partial melting can take place before the subsequent recrystallisation process,
which favours the more thermodynamically stable material, in this case the
extended chain crystal form of the polymer. This means that as the
temperature is raised, the metastable folded chain crystals melt first but
the extended chain crystals tend to persist, since insufficient time for
complete fusion is allowed. On cooling, recrystallisation as the extended
chain form on the extended chain crystals already present will occur. As
Figs. 4.23. and 4.24. show, extended chain structures lead to an increase
in the frequency factors for the different dielectric processes, which causes
the observed shift to higher frequencies following annealing.
It can be concluded therefore, that changes in the structure of PEG 4000
which result from alterations in its thermal history can be detected from
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4.3.1.3.	 Crystallisation behaviour
The temperature and time dependence of the crystallisation of PEG 4000
was investigated between 318 and 308K by measuring changes in capacitance
with time at a fixed frequency of 1778 Hz. Subsequently, frequency scans
were performed to check that the dielectric response associated with the
solid was present. Sigmoldal shaped graphs of capacitance as a function of
time were obtained for polymer crystallised at 318 and 313K, as would be
expected (Fig. 4.28). This is in contrast to the behaviour observed at the
lowest crystallisation temperature, 308K, where a peak was present
(Fig. 4.29.), suggesting that some differences occur in the crystallisation
process at this temperature. However, frequency scans performed after
crystallisation were identical at all temperatures to those obtained from
earlier measurements of the solid.
It is therefore possible that the time dependencies of the components
which influence the measured capacitance were different. For example,
the decrease in the bulk conductance on solidification could occur more
slowly than the change in bulk capacitance. A graph of capacitance as a
function of time, would show an apparent increase in the capacitance initially,
followed by a fall as the conductance starts to drop, giving the peak observed
at 308K. Alternatively, the influence of the conductance and capacitance
components on the observed capacitance may vary according to the
temperature of crystallisation.
It is expected that the crystaUisation of PEG 4000 would follow Avrami
growth kinetics (Avrami, 1939, 1940, 1941), where the equation for the






















Fig. 4.28.	 Capacitance at 1778 Hz as a function of time for crystallisation
of PEG 4000 at 313K
Time (mins)
Fi. 4.29.	 Capacitance at 1778 Hz as a function of time for crystallisation
of PEG 4000 at 308K
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in C00 1 - C = krtfla
coo,-co
where Coo' = capacitance at infinite time after start
C	 = capacitance at time t after start
C 0
 = capacitance at t = 0
kr = rate constant
... 4.34.
= Avrami exponent which has a value between 1 and 4
characterising the dimensionality time dependence
of growth
For example, ff T1a = 4, nucleation must be homogeneous (i.e. time dependent)
and growth must be three dimensional. However, for a = 3, two inter-
pretations are possible: either nucleation is heterogeneous (i.e. effectively
instantaneous) and growth is three dimensional or nucleation is homogeneous
and growth is two dimensional. The exponent is n necessarily an integer
since values of a = 1 .5, 2 • 5 or 3.5 are obtained where diffusion controlled
transport to the growth boundary occurs.
The value of the Avrami exponent is obtained through constructing
co-logarithmic pkts of in C00 ' - C	 as a function of time, the gradient
C 00 ' - C0
of which will correspond to	 A typical Avrami plct for crystallisation at
313K is presented in Fig. 4.30. It was nc possible to interpret the results
at 308K in this way due to the peak in capacitance/time curve. If this, for
example, arose as a result of two competing processes, then the maximum
value of the capacitance would not correspond to the true value of Coo'











Fig. 4.30. Avrami pict for PEG 4000 crystallising at 313K
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The values obtained here for a (I'able 4.4.) are less than the expected
value of 3 or 4 which is predicted where the growth of three-dimensional
spherulites is seen. However, PEG crystallisation cann be fitted to a
single Avrami equation In general and a wide range of values for na has been
observed with the different methods used to study the crystallisation kinetics.
For example, na was found to vary froni 2.2. to 3.2. when determined by
dilatometry, but from 1.4. to 1.8. when determined by calorimetry
(God ovsky et al, 1972). Many causes of the deviation from Avraml growth
kinetics have been postulated. Results obtained by DSC (Hay et al, 1969 )
showed the Avrami exponent to be dependent on preheating time and temperature.
However, removal of any thermal history such as was carried out here by
maintaining samples in the molten state at 363K for 1 hcur prior to crystal-
lisation should eliminate any differences between samples. Beech et al
(l972b) suggested that deviations from the expected value of a arose as a
result of secondary crystallisation processes • Fractionation by molecular
weight could occur, leading to attenuation of the crystallisaticn rate as the
crystallisation proceeded. Alternatively, the growing fronts of the spherulites
could impinge on each cther, which means that crystallites formed Initially as
spheres would become constrained to form discs (Hay et al, 1969 ). This
would correlate with experimental data where the value of na is determined
to be approximately 2, such as is observed here. Godovsky et al (1972)
have also suggested that the deviation occurs because the Avrami equation
applies only to primary erystallisation processes i.e. those involving
crystallites. They argued that spherulites are just secondary aggregates
which do nut contribute essentially to the energy parameters for either
crystallisation or fusion, since the heat of fusion for samples consisting of
- 203 -
Table 4.4. Crystaffisatici half times and Avrami exponents for PEG 4000
Crystallisation	 Crystallisation half time	 Avrami exponent





either a large number of small spherulites or a few large spherulltes is
equal provided the degree of crystallinity Is the same In bcth cases.
The calculated half times to crystallisation (t ) decrease as the
temperature of crystallisatlon is lowered (l'able 4.4.) indicating that the
rate of crystafllsation Increases with the degree of supercooling as would
be expected. From calorimetric and dilatometric studies, Godovsky et al
(1972) estimated the tc. of PEG 4000 at 319.9K as 17.4 mins which is
shorter than the value of 38 mins at 318K determined here. However, since
even small differences in experimental conditions and choice of the beginning
and end point of crystallisatlon will affect significantly the results obtained,
the values of t can be considered to be In reasonable agreement.
4.3.1.4.	 Melting behaviour
The time and temperature dependence of melting of PEG 4000 was
Investigated between 328 and 343K, above which temperature the transition
occurred too quickly to follow accurately. No melting transition was observed
In samples equilibrated at 328K although a rise in capacitance occurred
corresponding to the conversion to the extended chain form, as was confirmed
by a subsequent frequency scan which revealed that the dielectric response of
the solid was still present.
For temperatures from 333 to 343K, capacitance as a function of time
was measured at frequencies of 1778 and 10Hz. Graphs of data at the former
frequency exhibited peaks, whereas at the latter frequency, sigmoidal shaped
graphs were obtained. Typical examples for the melting transition at each
frequency at 333K are given In Fig. 4.3L and 4.32. respectively. Melting
half times (tm) at the two frequencies show good agreement and increase as








Fig. 4.31.	 Capacitance at 1778 Hz as a function of time for melting
transition of PEG 4000 at 333K
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FIg. 4.32. Capacitance at 10Hz as a function of time for melting
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Table 4.5.	 Melting transitk*i half times (tm) for PEG 4000
Temperature of	 Melting	 half time (tm) mins
melting








Table 4.6.	 Values of Avrami exponent for melting oltained from
data at 10 Hz for PEG 4000










treatments on the time dependent behaviour of melting was also investigated.
PEG 4000 which had been annealed, by cycling three times between the solid
and liquid states showed a two-fold increase in the melting half time. This
reflects the increase in the crystallinity and the higher proportion of extended
chain crystals present in this material, giving it a greater thermal stability
and hence increasing the time required for melting compared to unannealed
polymer. However, PEG 4000 which had been solidified by quenching in
liquid nitrogen showed at most a small decrease in the melting half time.
Since melting can be regarded as a process which involves nucleation
and growth of a new phase within another, it can be treated as a simple
reverse of crystallisation and thus Avrami growth kinetics may be expected
to apply. The values of the Avraml exponents calculated from the data at
10Hz for the different melting temperatures are presented in Table 4.6. and
range from 0.4 to 2.7. It has been postulated that nucleation occurs at
corners or lattice defects in the crystals since direct observation of PEG
single crystals embedded in liquid shows melting occurs by progressive
lateral shrinkage, often starting at the corners (Buckley and Kovacs, 1976).
These authors concluded that for the melting of extended chain crystals, a
model which Involves closely packed crystalline lamella without an intervening
layer of molecules in the liquid state is appropriate, as has been suggested
for melting in other polymers. It is expected that the Avraml parameter
for this mechanism would be 3 or 4. However, melting is a complex transition
and may be influenced by many factors. Thus it is not surprising that the
Avrami parameters calculated from the results here showed a wide range
of values and that no trends could be established.
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4.3.2.	 Trimethoprim
The dielectric response of trimethoprim in the solid was investigated
over a temperature range from 363 to 293K, below which temperature the
dielectric loss became too low to measure accurately.
The results could be normalised over the temperature range studied and
a normalisation curve is presented in Fig. 4.33. Circuit analysis of the
response showed that the system could be represented by:
(i) A frequency dependent capacitance in parallel with
(ii) A frequency independent capacitance
These two elements which characterised the barrier response were in series
with:
(iii) A frequency independent capacitance
(iv) A frequency dependent capacitance
(v) A conductance
All of these three elements were associated with the bulk response. The
characteristic parameters at the different temperatures are given in Table 4.7.
Temperature independent behaviour over the temperature range studied was
displayed by the Dissado-Hill shape parameters, the frequency independent
capacitances C	 and C oo 2 and the amplitude of the loss processes,
C(0) 1
 and C (0)2 for both barrier and bulk responses. However, Arrhenius
plots of the loss peak frequencies wp 1 and P2 as well as the bulk conductance,
Go2 revealed two different regions of temperature dependent behaviour which
were similar for all three parameters. Between 363K and 333 K, the observed
process exhibited only weak temperature dependence with a calculated activation
energy of —0.2 eV in all cases. Below 333K, a sharp increase in the gradient
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Fig. 4.34. Arrhenius pict for buLk loss peak frequency for trimethoprim





Activation energies of characteristic parameters of
trimethoprim determined from circuit analysis
Parameter	 High temp. process (363-333K) 	 Low temp. c333-293K)
(eV)	 Corre'ation	 (eV) Corre]ation
cu 1, 1.	0.195	 0.9851	 2.05	 0.9997
(L)p2	 0.209	 0.9864	 2.04	 0.9998
G02	 0.209	 0.9864	 2.04	 0.9998
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rising to — 2.05 eV. A typical Arrhenius plot of the barrier loss peak
frequency (w i) is presented in Fig. 4.34., and the values of the activation
energies for all three parameters in Table 4.8.
Since all the temperature dependent processes exhibit the same activation
energy, it appears that the conduction and dipole relaxation, which must occur
in a crystalline environment, arise through hydrogen bond transfer, coupled
to -OCH3 side group rotations and twisting about the -CH 2 bond. Neutron
diffraction studies (Koetzle and Williams, 1976) indicate that extensive
hydrogen bonding can occur to give a ribbon like network, with N) and N(2)
of the pyrimidine ring acting as receptor and donor respectively across one
centre of symmetry, and N) and N(4) acting similarly across another. At
high temperatures, the activation energy for the process of —0.2 eV
corresponds to —1650 vcm 1 . I.R. studies (Bettinetti et al, 1976) show a
strong absorption band at this wavelength.
At low temperatures, the high activation energy of — 2.0 eV is consistent
with transport of charge by hydrogen bond 'hopping', which occurs together
with dipole reorientation, and is likely to involve twisting of the CH2 bridge.
4,3.3.	 Solid dispersions of PEG 4000 and Trimethoprim
4.3.3.1.	 Liquid state
Dispersions containing 2%, 10% and 50% 	 trimethoprim in PEG 4000
were fused completely at 473K for 10 mInutes prior to pouring into the dielectric
cell at 363 K, which was the highest temperature that could be achieved with
this experimental system. Frequency scans of the solid dispersions were
performed as for PEG 4000 and composite curves of the response at different
temperatures for each concentration are given in Fig. 4.35a., b. and c.
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FIE. 4.35.	 Composite graph of frequency response for molten PEG 4000
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Normalisation of the data could not be carried out since the components of
the response displayed different temperature dependent behaviour relative
to each other. As can be observed from the composite graphs of the dielectric
response, there is an anomalous decrease in the capacitance at frequencies
of approximately lO3Hz for all concentrations of trimethoprim, which often
became more pronounced as the temperature was lowered. This type of
behaviour is usually observed where resonance effects are present. Since
this behaviour was never observed for PEG 4000 alone, electrode bending or
resonating effects can be eliminated as the cause, which tends to suggest that
the resonance effect arises from the presence of the drug. The oscillation
is prthably due to the effect of polarisation induced by the field on the particles
of drug since it is enhanced as the drug content increases (Armstrong and
Edmondson, 1973). At high frequencies, the induced charges are not able to
respond to the field, except within the particle itself, thus the capacitance is
positive. At lower frequencies, the positive ions drawn to the drug particles
overcompensate for the induced negative charges on the drug particles (and
vice versa) and the capacitance becomes negative. For very low frequencies,
the conductance in series with the harrier contributes to give a positive
capacitance.
Unfortunately, circuit analysis of the responses could not be carried out
because of the high frequency behaviour of the capacitance, which led to an
unacceptably high degree of uncertainty in the curve fitting procedure.
However, estimates of the conductivity can be obtained from the loss curve
for each concentration of trimethoprim. There is an increase in the
conductivity at all concentrations of drug, relative to that of the polymer melt
alone, suggesting that some of the trimethoprim has dissolved and is acting
- 218 -
as a charge donor. The conductivity of the lO%W/W and 50%W/w dispersions
is reduced compared to that of the 2% W/W dispersions, as would be expected,
since the volume fraction of the polymer has decreased.
4.3.3.2.	 PEG 4000 and Trimethoprim solid dispersions - solid state
The frequency responses of PEG 4000 and trimethoprim solid dispersions
investigated in the solid state as for the polymer alone could be norrnalised
for all concentrations of drug. Normalised curves of the data are presented
in Fig. 4.36. to Fig. 4.38. As with PEG 4000, the results obtained in the
liquid and solid states cannot be fitted together. Moreover, hysteresis
between the cooling and heating cycles is again observed.
The dielectric response of the solid dispersions could be interpreted at all
the concentrations of drug studied in terms of the circuit diagram given for
PEG 4000. Even at the highest concentration of 50% W1 trimethoprim, no
separate dielectric response attributable to the drug was observed and that of
the polymer predominated. The Dissado-Hill shape parameter n = 0.2
associated with the barrier response remained unchanged in the presence of
the drug, suggesting that the behaviour and structure of the barrier is similar
to that postulated for PEG 4000. It is possible that the polymer Is preferentially
'adsorbed' onto the electrode surface rather than the drug, or that the amount
of drug molecules present in the barrier layer is insufficient to influence its
behaviour.
Scaling of the magnitudes of the individual parameters was achieved by the
usual computer curve fitting procedure and the results are given in Tables 4.9.
to 4.14. for cooling and heating cycles of 2%, 10% and 50% W/ trimethoprim
solid dispersions. The Dissado-Hill shape parameters at all concentrations
are similar to those obtained for PEG 4000, indicating a fairly wide range of
Na-i
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Fig. 4.36. Norrnalised curve of frequency response for PEG 4000 and
2%W/w trimethoprim solid dispersion
a. On cooling cycle
—a
(d) 0)/D20'l D 20'i
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Fig, 4.37. Normalised curve of frequency respcise for PEG 4000 and
10% V/w trimethoprim solid disperskx	
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Fig. 4.37.	 b. Oa 1atlng cycle
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Fig. 4.38. Normalised curve of frequency response for PEG 4000 and
5O% W /W
 trimethoprim solid dispers ions
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dipole relaxations but with some local correlated motion. As with PEG 4000,
the loss peak frequencies of the bulk and barrier responses and the bulk
conductance displayed temperature dependent behaviour. Arrhenius plots
constructed for these parameters (Figs. 4.39. to 4.44.) revealed that the
activation energies for the heating and cooling cycles and for all three
components were the same for any given concentration of drug. However,
the amount of trimethoprim in the solid dispersion did appear to influence
the activation energy. At 2% W /W, the calculated activation energy at
—
0.93 eV was slightly lower than that of the polymer which was —1.1 eV.
Conversely, at the other two concentrations of trimethoprim, namely 10% w/w
and 50% W/w, higher activation energies of —1 .3 eV and —1 .4 eV respectively
were observed. In all cases, an anomalous increase in the values obtained
for these parameters on the heating curve above 318K was seen, which was
mirrored by a corresponding decrease in the previously temperature
independent loss peak amplitudes of the bulk and barrier processes. This
behaviour is again similar to that observed for PEG 4000 in the absence of
any drug.
As the conductance and loss peak frequencies exhibit the same temperature
dependence for both heating and cooling data, it can be assumed that the same
molecular motion is involved. Furthermore, since the same circuit elements
are involved here as for PEG 4000, it is not unreasonable to assume that the
observed relaxation process and conductance arise from the same molecular
motion as for the polymer. Thus the ac relaxation seen in the polymer
appears to be present in these solid dispersions also, although the activation
energies associated with it are slightly different. At high concentrations of
trimethoprim, that is both 10% and 50% W /W, the increased activation energy
- 232 -
Fig. 4.39.	 Arrhenlus picts for barrier and bulk loss peak frequencies
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Fig. 4.40.	 Arrhenius picts for bulk conductance on heating and cooling
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Fig. 4.41 • Arrhenius plcs for bulk and barrier loss peak frequencies on





























Fig. 4.42.	 Arrhenius plots for bulk conductance on leating and cooling


















Fig. 4.43. Arrhenius plcts for bulk and barrier loss peak frequencies
on heating ad cooling cycles for PEG 4000 and 50%"/w
trimethoprim solid dispersk*is
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Fig. 4.44.	 Arrhenius pls for bulk conductance on heating and cooling
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implies that the relaxation route, which also gives rise to the d.c. charge
transport process, is more difficult than in the polymer alone. Since the
ac relaxation process takes place on the surface of the crystalline lamella
and involves mainly the chain ends and folds with only a limited degree of
main chain distortion inside the lamella, it seems reasonable to assume that
the drug molecules are also outside the crystal itself. This again tends to
confirm the results from DSC and X-ray diffraction studies in Chapter 3
which suggest that negligible eutectic or solid solution formation occurs
with this system. If a eutectic or solid solution were present, then it
would be expected tint a totally different dielectric response to that of the
polymer alone would be observed, due to the disruption of its structure.
However, this is not found here. Thus the presence of the, drug does not
prevent the relaxation and charge transport processes present in the polymer
but does alter the ease with which they occur. The high concentrations of
drug obviously hinder these processes, since a high concentration of drug
molecules and or crystals would be expected at the lamellae interfaces.
It should be remembered that impurities, which would include the drug here,
tend to be rejected during the primary crystallisation process and are not
incorporated into the crystal. The slight decrease in the activation energy
observed when 2%"/w trimethoprim is added to the polymer seems to
indicate that at this low concentration of drug the relaxation route in
PEG 4000 is facilitated by its presence.
Further evidence for the drug and polymer behaving as separately
crystallising entities comes from the anomolous behaviour dbserved above
318K on the heating cycle. For PEG 4000, this was attributed to the ]ameUa
thickening process which resulted in chain extension of folded chain crystals
- 239 -
to their fully extended form. Since this mechanism appears able to occur in
the presence of even high concentrations of trimethoprim, and at the same
temperatures as for the polymer alone, It suggests that the presence of the
drug doe n hinder chain unfolding. Again, this correlates well with the
drug molecules being outside of the actual polymer lameliae.
No enhancement of the low temperature (3relaxation process or
reduction of the c process, which was observed after quenching PEG
4000 to a more amorphous form was apparent for any of the solid dispersions.
Thus it appears that the addition of drug molecules does n result in a
significantly higher proportion of amorphous material, and hence has nct
markedly hindered the polymer crystallisaticwi.
4.3.3.3. Crystallisation behaviour
The temperature and time dependence of the crystallisaticn of solid
dispersions of PEG 4000 and trimethoprim was investigated as for the
polymer alone hapter 4.3.1 .3.). For the solid dispersions crystallised
at 318 and 313K, sigmoidal shaped graphs of capacitance as a function of
time were observed, which was in contrast to the behaviour at 308K where
these graphs displayed a maximum. These results follow a similar pattern
to those obtained for the polymer alone (see Figs. 4.28. and 4.29.) which
suggests that the same mechanism of crystallisaticii can occur even if high
concentrations of drug are present. The rise and fall in capacitance at
308K therefore probably results from the composite effects of the changes
in the bulk conductance and capacitance suggested for PEG 4000.
Crystauisation half times are presented in Table 4.15. for all
concentrations of trimethoprim in PEG 4000 studied. There does n appear
to be any significant difference between the crystallisaticn half times of the
- 240 -
Table 4.15.	 Crystallisatic*i half times (tc.) for PEG 4000 and
trimethoprim solid dispersions
	
Concentration of	 trimethoprim	 t at crystallisation temperature of (K)
(%W/w)	 318	 313	 308
	
2	 43	 28	 16
	
10	 49	 25	 12
	
50	 52	 30	 18




	 trimethoprim	 Avrami exponent na at









polymer alone or in the presence of trimethoprim, except for a slight
Increase at high temperatures for 50%"/w solid dispersions. Since drug
particles are known to be present at this concentration, this may reflect
the additional time required for orientation of the polymer chains during
nucleation and growth, which may be hindered by the presence of these
particles. No evidence of the drug particles acting as nucleating agents
for crystallisation of the polymer could be detected, since the crystallisatlon
times Increased slightly instead of being reduced. Thus it seems that the
polymer crystallisation process is essentially independent of the concen-
tration of trimethoprim added.
The values of the Avrami exponent were found to range between 1.9
and 2.3 at a crystallisation temperature of 318K and 1 .8 and 2.3 at 313K
(Table 4.16.). Values of a could not be calculated from data at 3 08K,
where the graphs of capacitance as a function of time displayed peaks, for
the reasons outlined in Chapter 4.3.1.3. No significant differences were
noticeable between solid dispersions containing different concentrations
of trimethoprim, or between the two crystallisation temperatures.
Furthermore, all these values Of tia are in the same range as those
calculated for PEG 4000 alone • Thus it appears that the presence of the
drug does not alter the fundamental crystallisation kinetics of the polymer.
This crystallisation behaviour of PEG 4000 and trimethoprim solid
dispersions tends to corroborate the results obtained by DSC and X-ray
diffraction methods (Chapter 3.3.2.), which suggest that no eutectic or
solid solution formation occurs to any detectable extent for this system.
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4.3.3.4.	 Melting behaviour
Investigations of the temperature and time dependence of the melting
transition of solid dispersions of PEG 4000 and trimethoprim at 1778 Hz
were performed as for PEG 4000 alone. No melting transitions were
apparent in samples equilibrated at 328K which is similar to the behaviour
observed for the polymer alone. This suggests that the presence of the
drug does nct significantly depress the melting point of the polymer from
330K, as would be expected if a eutectic or solid solution system were
formed, and corroborates the results obtained in Chapter 3.3.2. For
temperatures from 333 to 343K, graphs of capacitance as a function of time
exhibited maxima, which is again similar to the behaviour determined for
PEG 4000 alone.
Melting half times (tm) are presented in Table 4.17. and decrease as
the temperature of melting Is raised. These values are in good agreement
with those obtained for PEG 4000, suggesting that the melting behaviour of
the polymer is independent of the concentration of drug present. The presence
of the drug neither decreases the melting half time of the polymer as would
be expected for a eutectic, nor does it increase this parameter as might
be expected for a more highly crystalline sample or one which contained a
higher proportion of extended chain crystal lameUae. This latter effect is
illustrated by annealed PEG 4000 which showed that the melting haLf time
was double that of the unannealed polymer. Small reductions in polymer
crystallinity however do nct seem to affect the melting half time, in the
range studied. As can be seen from Chapter 4.3.1.4., quenched PEG 4000
showed little reduction in this parameter compared to crystalline samples.
Thus solid dispersions which DSC results (Chapter 3.3 .2.) suggest may
- 243 -
Table 4.17.	 Melting hail times for PEG 4000 and trimethoprim solid
dispersions
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contain a higher percentage of amorphous material e .g. 50% W/w dispersions,
cann be distinguished from more crystalline solid dispersions by melting
half times.
Avrami pkts could n be constructed from this data owing to the shape




CHAPTER 5 Dissolution behaviour
5.1.	 Introduction
In spite of the number of dissolution studies which have been performed
on PEG-drug solid dispersions, the precise mechanisms involved in
enhancing the drug release often have not been elucidated. At present, no
definite correlation between physical structure and drug release exists in
most cases. Furthermore, changes in dissolution rate on ageing have not
been related to alterations in structure of the solid dispersion. Various
explanations of the drug dissolution enhancement have been postulated, which
are summarised below.
(i) Particle size reduction of the drug was suggested by Sekiguchi and
Obi (1961) to explain the increased dissolution rate of a eutectic mixture of
suiphathiazole and urea compared to that of the drug alone, since the carrier
did not exert a solubilising action on the drug nor did it enhance its
physiological absorption. The soluble carrier dissolves rapidly releasing
a micro-crystalline suspension of the drug with an increased surface area
and hence usually a higher rate of dissolution relative to the pure drug.
Similarly, for solid solutions where the drug is crystallised as single drug
molecules, the maximum surface area is available, which should result in
an increase in dissolution (Goldberg et al, 1966). Evidence has been
presented by Corrigan et al (1979) from their studies on the dissolution
rates of both drug and polymer in support of molecular dispersion as an
important factor in enhancing the drug dissolution. McGinity et al (1984)
noted that flash cooled solid dispersions of tolbutamide in PEG 6000 had a
signficantly faster dissolution rate than slow cooled solid dispersions.
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This was attrthuted mainly to a particle size effect since smaller particles
of drug would be expected in the rapidly cooled dispersions.
(ii) Mjcroenvironmental solubiisation of the drug by the carrier may
occur in the diffusion layer surrounding the drug particle hiou and
Riegelman, 1971 ). PEGS have been shown to Increase the aqueous
solubility of many drugs -Iargreaves, 1982; Chicu, 1977; SaJJb and Ebian,
1978; Kaur et al, 1980b) but generally concentrations of more than lO%\V/
of polymer are required before any appreciable solubiisation is observed.
As a result, many workers have discounted the possibility of microenvircn-
mental solubilisation. Corrlgn et al (1979) calculated that the theoretical
maximum for enhanced drug dissolution due solely to the solubility enhancing
effect of the dissolving polymer was below that of the experimentally observed
enhancement. However, Hargreaves (1982) suggested that higher concen-
trations of PEG may exist in the diffusion layer than had previously been
thought and consequently this mechanism cannct be excluded.
(ill) An increase in the actual solubility of the drug may be observed if
the crystallites are very small hiou and Riegelman, 1971 ). Alternatively,
a metastable polymorph or the amorphous form of the drug may be present
In the solid dispersion. Bcth of these forms would be expected to exhibit a
higher solubility than the original crystal form due to their increased
surface free energy (Hajratwala, 1974).
(iv) Increased wettability of the drug particles resulting from their
intimate contact with the hydrophilic polymer molecules has been proposed
by many workers as an important mechanism in the enhanced dissolution
rate (Ho and Hajratwala, 1974; SaIth et al, 1976; Chiou and Riegelman,
1971 )• Kim and Jarowski (1977) have demonstrated that lowering the surface
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tension resulted in an increase in the dissolution rate of hydrocortis one from
solid dispersions. Moreover, studies performed by Hoelgaard and MØller
(1975) on the dissolution rate of sparingly soluble drugs formulated as solid
dispersions in PEG 6000 or as optimally dispersed and wetted suspensions
showed little difference between the two dosage forms. Thus wetting of the
drug by the polymer may contribute significantly to the dissolution enhance-
ment.
(v) Decreased aggregation and agglomeration between the particles of the
drug hiou and Riegelman, 1971 ). Fine hydrophobic powders often form
aggregates (particles which are held together by strong inter or intra
molecular cohesive forces) and agglomerates (particles which are held
together by weaker cohesive forces) as a result of their increased surface
energy. This decreases the surface area available for dissolution. Since
in solid dispersion systems, the drug particles are surrounded by hydro-
philic polymer, this problem should be removed.
The observed dissolution enhancement of the drug may well result from
a combination of the above mechanisms and the relative importance of
individual factors may vary from system to system. Changes in the
structure of drug-polymer dispersions which arise from differences in
the manufacturing conditions or as a result of ageing may or may nut have
a significant effect on the dissolution rate depending on the mechanisms
Involved. For example, if particle size reduction is the most important
factor in the observed enhancement of dissolution rate, then changes in the
manufacturing conditions, such as cooling rate may have a marked influence.
Conversely, if microenvironmental solubilisation or improved wetting
predominate as the mechanisms of dissolution enhancement of the drug,
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these would be expected to be influenced less by changes in the structure of
the dispersion.
5.2.	 Methods
5.2.1.	 Intrinsic dissolution rate determination
The dissolution apparatus consisted of 1 litre round bottomed flasks
containing 1 litre of distilled water as the dissolution medium, maintained
at 37°C ± 0.1°C in a water bath (Dissolution system 2000, Copley
Instruments Ltd., Nottingham). The constant surface area discs, prepared
as described in Chapter 3, were ccated with molten paraffin wax such that
only the flat surface was available for dissolution. Care was taken to
ensure that no localised fusion occurred on the disc surface whilst carrying
out this procedure since this might alter the characteristics of the dissolution
surface. Subsequently, discs were attached centrally to the lower surface
of the rotating shaft and held 6 cm from the bottom of the flask. Several
agitation intensities were investigated to determine if the system was
diffusion controlled. Two ml samples were withdrawn through a 0.45 j.m
filter at suitable intervals from a point halfway between the disc and the
flask wall, level with the surface of the disc. Duplicate determinations
were performed in all cases and the results averaged.
5.2.2. Assay method for PEG 4000
PEG 4000 was assayed using the nthod of Childs (1975) where a
coloured barium iodide complex is produced which can be determined
quantitatively at 535 nm.
The procedure adopted was as follows: 1 ml of 5%W/v Barium chloride
in 1M Hydrochloric acid and 0.5 ml 0.05M iodine solution were added to
4 ml of PEG solution, which was then mixed thoroughly by shaking. After
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standing for 15 minutes, the optical deusity was read at 535 nm using a UV/vlsible
spectrophotometer E292, Cecil Instruments, Cambridge). Blank solutions
consisting of distilled water treated similarly were assayed and duplicate
determinations were performed in all cases. The influence of trimethoprim
cxi the assay was investigated by using saturated solutions of the drug instead
of water, and was found not to affect the results.
5 • 2.3. Assay method for Trimethoprim
Assay of this drug was carried out by UV spectrophctometry E292,
Cecil Instruments Ltd., Cambridge) at 270.5 nm. The effect on the
assay of adding PEG 4000 was also determined, and was found not to
influence the results at the concentrations present.
5.2.4. Solubility determination
The solubifity of trimethoprim was determined in distilled water and
aqueous PEG 4000 solutions at concentrations of O.5_60%W/w as follows.
Approximately 1 g of trimethoprim together with 10 ml of solvent were
placed in a tightly stoppered tube, secured with parafilm, shaken vigorously
by hand periodically and equilibrated for 24 hours in a constant temperature
oven at 37°C. PrelimInary studies indicated that equilibrium solubiity
was attained within this period of time. After equilibration, the tube
contents were filtered through a 0.45 p.m millipore filter. The first 4 ml
of filtrate were rejected to preclude any filter adsorption effects and the
remainder was diluted and assayed by UV spectroscopy as described in
5.2.3. Each solubility determination was carried out in duplicate.
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5.3.	 Results and Discussion
5.3.1.	 PEG4000
5.3.1.1.	 Effect of thermal history
The dissolution behaviour of PEG 4000 prepared under a variety of
heating and cooling conditions, and studied at stirring rate of 80 rpm,
displayed in all cases a dissolution profile similar to that illustrated in
Fig. 5.1. Intrinsic dissolution rates (mgcm2min) were calculated
from the gradients of the linear portion of the graphs and correlation
coefficients were always better than 0.98. All dissolution profiles exhibited
a positive curvature initially, confirmed by the negative intercept of the
graph, which has been attributed to swelling of the polymer (Heyd et al,
1969). Calorimetric studies of the heat of solution of PEGS showed that
two distinct processes occurred in immersing the polymer In water - an
initial endothermic process, rapidly followed by a second exothermic
reaction (Ikeda et al, 1975). Further studies indicated that if the dissolution
was into a saturated solution of PEG, then the latter reaction was not
observed. Thus it was concluded that the first process observed related
to the swelling and the second to the dissolution of the polymer. These
processes are thought to occur simultaneously where the volume of
dissolution fluid is large, as In the conditions used in this study.
N.M.R. studies (Liu and Parsons, 1969) on the behaviour of PEGS in
aqueous solution suggest that each ethylene oxide unit is hydrated by three
water molecules and that much of the trans-gauche-trans sequence and
helical conformation associated with the crystalline solid is retained, a

















Fig. 5.1.	 Representative example of intrinsic dissolution profile of PEG 4000




As can be seen from Table 5.1., the temperature of melting and time
in the molten state exerted little influence on the dissolution rate of PEG
4000, except when the polymer had been melted at 200°C for 10 hours,where
a slight increase In dissolution rate was observed. The information about
the structure of PEG 4000 obtained by DSC and X-ray diffraction which is
presented in Chapter 3.3.1. showed a corresponding decrease in the heat
of fusion for that sample. Thus, the increase in dissolution rate can be
attributed to the break-up of polymer chains into shorter molecular weight
fragments and to a decrease in the overall crystallinity. It has been reported
(Corrigan et al, 1979) that a decrease in the molecular weight of
PEGS results In an increase in the dissolution rate. Although differences
in the morphology of PEG 4000 melted at different temperatures for various
periods of time could be detected by DSC, it appears that these changes are
nc reflected by differences between the intrinsic dissolution rates observed.
However, changes in the cooling rate were found to influence the
subsequent dissolution rate of the polymer (l'able 5.2.). A significant
increase in the dissolution rate of PEG 4000 quenched in liquid nitrogen
was ncticeable compared to more slowly cooled samples, although the
effect on the dissolution rate of less dramatic differences in the cooling
rate i.e. between 20°Chr and 5°Chr, was negligible. This increase
in dissolution rate can be attributed to the higher percentage of amorphous
material present in the quenched specimens, as can be seen from the data
obtained by DSC in Chapter 3 .3.1. The heat of solution of the amorphous
form of the polymer is much less endcthermic than that of its crystalline
counterpart (ikeda et al, 1975) and therefore it Is expected that the
dissolution of the more amorphous sample of PEG 4000 would be more rapid.
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Table 5.1.	 Effect of temperature of melting and time In the molten state
on the intrinsic dissolution rate of PEG 4000
(Cooling rate of samples = 20°Chr1)
Time in molten state	 Intrinsic dissolution rate after melting at
(mgcm2mIn1)
60°C	 100°C	 200°C
10 mInutes	 16 .68	 16 .75	 16 .66
lhour	 17.15	 17.12	 17.15
lOhours	 16.91	 16.68	 17.48
Table 5.2.	 Effect of cooling rate on the lntrinsic dissolution rate of
PEG 4000
Cooling rate after	 Intrinsic disolution rate
melting at 100°C for 1 hour	 (mgcm min)





These results suggest that the crystal morphology present - either folded
or extended chain type - does n exert a great influence on the dissolution
rate of the polymer but that changes in the degree of crystallinity do have
a marked effect. Nevertheless, substantial differences in the thermal
history of PEG 4000 are necessary before changes in the dissolution
behaviour are apparent.
5.3.1.2.	 Effect of ageing
The effect of ageing on the dissolution behaviour of PEG 4000 was
investigated using samples of polymer which had been cooled at different
rates, since these displayed the widest initial range of dissolution rates
(see previous section). After ageing at 25, 37 or 45°C for 6 months, all
samples exhibited decreased dissolution rates relative to their initial
profiles. Furthermore, although the different batches bad widely differing
initial dissolution rates, after 6 months, all the dissolution rates had fallen
to approximately the same level of —l6mgcm 2 min' (Fig. 5.2a., b., c.).
The most rapid decrease in dissolution rate was cbserved during the first
month and in most cases, the majority of the decrease occurred in the
first two months. As would be expected, increasing the temperature of
storage accelerated the rate of change in the samples but no significant
difference between dissolution rates after six months at any of the storage
conditions was apparent.
The changes in the dissolution profile of PEG 4000 correlate well with
the changes in the structure of the polymer observed under similar ageing
conditions by DSC and X-ray diffraction in Chapter 3. An increase in the
overall crystaUi.nity of the polymer and conversion of folded chain crystals
to the thermodynamically stable extended chain form seem to be mirrored

















Fig. 5.2.	 Effect of ageing on intrinsic dissolution rate of PEG 4000 at
various temperatures -
b.	 37°C
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PEG 4000 melted at 100°C for 1 hour and
Quenched in liquid nitrogen
A Cooled at 20°Chr1
. Cooledat5°Chr
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by a corresponding decrease in the dissolution rate • The quenched samples
of PEG 4000, which were the least crystalline initially, displayed the largest
subsequent decrease in dissolution rate as recrystallisation occurred,
whereas the slowest cooled polymer samples showed only a small decrease
in dissolution rate on ageing, since they were highly crystalline to begin
with. Presumably, the decrease in dissolution rate is halted once the polymer
has achieved Its maximum crystallinity, as the results here suggest.
Increasing the storage temperature will facilitate the annealing and secondary
crystallisation processes but will n alter the final level of crystallinity.
5.3.1.3.	 Effect of agitation intensity of dissolution rate
The dissolution behaviour of the two hatches of PEG 4000 representing
the extremes of dissolution rate obtained, namely those samples which had
been melted at 100°C for 1 hour and then either quenched in liquid nitrogen
or cooled at 50C hr4 , was investigated further. Intrinsic dissolution rates
were obtained at various stirring rate conditions between 50 and 120 rpm
ani the results are presented in Table 5.3. Below 50 rpm, the dissolution
profile became erratic because of inadequate mixing of the bulk dissolution
fluid and above 120 rpm, adequate sampling proved difficult due to the speed
of dissolution of the polymer. As expected for a diffusion controlled system,
the dissolution rate increased linearly as the stirring rate increased (Fig.
5.3.). Quenched PEG 4000 displayed a higher dissolution rate than the more
crystalline samples at all agitation intensities studied.
Cooper and Kingery (1962) related the diffusion controlled rate of
dissolution from the surface of a rcating disc to the stirring rate by the
following expression:
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Table 5.3.	 Intrinsic dissolution rates of PEG 4000 with different thermal
histories at various agitation intensities
Dissolution rate (mgcm2minl)
Agitation intensity (rpm)	 for PEG 4000 melted at 100°C for 1 hr then









Table 5.4. Estimated values of the diffusion layer thickness and diffusion
coefficients for PEG 4000 under various conditions
Agitation intensity Diffusion layer 	 Diffusion coefficients (cm2sec)
	
(rpm)	 thickness (cm) after melting at 100°C for 1 hour andQuenching x io Cooling at 5°Chr 1 x
	
50	 0.110	 3.66	 3.37
	
80	 0.087	 3.59	 3.22
	
100	 0.077	 3.45	 3.08
	
120	 0.071	 3.43	 3.21
/93 9
.
	 Cooled at 5°Chr1
Correlation = 0.9968
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Fig. 5.3.	 Intrinsic dissolution rate of two batches of PEG 4000 prepared





















where H = dissolution rate (mgcrn2min)
b = constant
SR = rate of stirring (rpm)
Thus:
... 5.1.
Log H = logb+0.5 log SR	 ... 5.2.
and a graph of log H as a function of log SR should have a slope of 0.5 with
intercept log b. The graphs contructed from the data above (Fig. 5.4.) gave
the relationship between stirring rate and intrinsic dissolution rate as:
I-I = 2.82(SR)°428
for quenched PEG 4000 and
H = 2.56(SR)°429
for PEG 4000cooledat 5°Chi1
In both cases, the value of the exponent is less than the predicted 0.5, as
has been found for other systems (Muhammed, 1980). Nevertheless, the




5.3.1.4. Estimation of the diffusion layer thickness and diffusion
coefficients
The diffusion layer thickness for a solvent flowing over a dissolving solid
may be estimated from (Nelson, 1957):
h =	 . . . 5 .4
p(rps)
where h = the thickness of the diffusion layer (cm)
= viscosity of tie dissolution medium (poise)
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Fig. 5.4. Relationship between log stirring rate and log dissolution rate
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A	 Quenched in liquid nitrogen
Correlation = 0.9992
•	 Cooled at 5(1
Correlation = 0.9939
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p = density of the medium (gml')
rps = stirring rate in revolutions per second
The maximum concentration of PEG 4000 that could be achieved in the
bulk dissolution fluid during the period of dissolution was calculated as less
than O.05%"/w, even at the fastest stirring rate. Therefore, the values
for the viscosity and density of the dissolution medium substituted into the
above equation were those for water at 37°C, since the error introduced
by this assumption was estimated to be minimal. The values of the
thickness of the diffusion layer for PEG 4000 under different agitation
intensities are listed in Table 5.4. Its thickness was found to be inversely
proportional to the stirring rate and as anticipated, the diffusion layer
became thinner as the stirring rate rose.
The equation derived by Nernst and Brunner (1904) was used to estimate
the diffusion coefficients:
H=D(C-C)	 . . . 5.5.
h
where H = dissolution rate per unit area (mgcm 2 sec1)
C'= equilibrium solubility of solute (mgml1)
C = concentration of solute in dissolution medium (mgml4)
h = diffusion layer thickness (cm)
D = diffusion coefficient of solute (gm2secl)
Under sink conditions, d'can be considered negligible in comparison to
and thus equation 5.5. may he simplified to:
H=D.0	 ... 5.6.
h
which can be rearranged in terms of the diffusion coefficient as:
D=H.h	 ... 5.7.
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The equilibrium solubility of PEG 4000 was estimated as 750 mgmr1,
which is slightly higher than the value of 706 mgml 4
 obtained by Corrigan
etal (1979). As can be seen from Table 5.4., the value of the
diffusion coefficient generally decreases as the agitation intensity increases
for bcth batches of PEG 4000 investigated. As these two samples delineate
the range of dissolution rates observed for PEG 4000 before ageing, all
cther values can be expected to lie between the range of diffusion coefficients
calculated here. The values of the diffusion coefficient calculated here are
approximately an order of magnitude higher than that measured for PEG 4000
by Corrigan et al (1979). However, their value of 3.1 x 1(16 cm2
 sec1
was obtained by the method of Goldberg and Higuchi (1968) which utiises a
stirring rate dependent barrier and thus the hydrodynamics are unlikely to
be equivalent to those here. Moreover, it should be stressed that the values
calculated here are purely estimates, although they demonstrate the
qualitative behaviour of the system.
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5.3 .2. PEG 4000 and trimethoprim solid dispersions
5.3.2.1.	 Aqueous solubility of trimethoprim
The solubility of trimethoprim in aqueous PEG 4000 solutions increases
rapidly at high concentrations of polymer, being about twenty six times more
soluble in 60%W/v PEG 4000 than in water (Fig. 5.5.). However, relatively
little increase in solubiity of drug is observed below 10%W/y PEG 4000.
Since PEG is a hydrophilic polymer, with no lipophilic moiety as is present
In a surfactant, it Is nc regarded as having pctential as a solubilising agent.
Recently though, Patel et al (1981) have shown for a variety of hydrophobic
drugs that the site of solubilisatlon within a polyoxyethyiene (20) glycol
monohexadecyl ether micelle was nut the hydrocarbon core as expected, but
the hydrophilic PEG mantle, especially the dehydrated PEG region next to
the core. Thus, a solubility enhancing effect by PEG 4000 would appear to
be feasible, where solubiisation is defined in its most general terms as
"the preparation of a thermodynamically stable isotropic solution of a
substance normally insoluble or very slightly soluble in a given solvent by
the introduction of an additional component or components" (Elworthy et al,
1968).
Many workers have investigated the effect of PEGs on aqueous drug
solubility, but in general using polymer concentrations below 1O%"/V
(e.g. El-Garnal et al, 1978; El-Gindy et al, 1983; Kaur et al, 1980b;
Khalil and Mortada, 1978). As here, little solubilising effect is observed
and therefore microenvironmental solubilisation has been discounted as an
Important factor in the enhancement of drug dissolution. However, the
diffusion layer would be expected to contain a much greater concentration
of PEG than the bulk fluid. Furthermore, swelling of the polymer on initial
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Fig. 5.5.











%W/w PEG 4000 concentration
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contact with water prior to dissolution may contribute to produce a very
dehydrated layer adjacent to the dissolution surface. Where studies of drug
solubility in aqueous solutions containing high concentrations of PEGS have
been performed (e.g. Hargreaves (1982) for betamethasone alcohol in PEG
6000, Elworthy and Lipscomb (1968) for griseofulvin in PEG 1000), a similar
rapid increase in solubility at higher aqueous PEG concentrations to that
obtained in this work is reported. Microenvironmental solubilisation may
therefore play a more important role than previously thought in enhanced
drug dissolution from PEG solid dispersions.
5.3.2.2.	 Effect of thermal history
To elucidate bcth the effect of different thermal histories and the probable
mechanisms of enhanced drug release from PEG 4000-trimethoprim solid
• dispersions, data on the dissolution of bcth components is required. The
intrinsic dissolution rate of trimethoprim alone was assessed as 0.054 mgcm 2 -
min 1 at 80 rpm from fused discs of drug.
For dispersions previously heated at 100°C for 10 minutes and cooled at
20°Chr 1 , the dissolution rate of trimethoprim increased linearly as a
function of composition up to 10%"/w, with a gradient of 0.217 mgmin1%4,
then remained steady to 20%"/w before decreasing dramatically at higher
drug concentrations (Fig. .5.6.). As sink conditions prevailed throughout
dissolution, this decrease cannut be attributed to a saturation solubility effect.
Despite the relatively poor dissolution performance at high concentrations of
trimethoprim, its formulation as a solid dispersion resulted in a marked
enhancement of dissolution rate compared to that of the drug alone.








Release rate of trimethoprim from dispersions previously
melted at 100°C for 10 mins and cooled at 2O°Chr'
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50%W/w trimethoprim dispersions revealed that the release rate of PEG 4000
was slower than for the pure polymer and that it decreased with increasing
drug concentration (l'able 5.5.). Since small amounts of hydrophobic materials
can markedly alter the hydrophilic characteristics of a material, then the
overall wettability of the dispersion may be expected to decrease as the
proportion of the hydrophobic constituent rises. l-largreaves (1982) reported
a sharp increase in the contact angle measured for water on solid dispersions
of PEG 6000 and betamethascrte alcohol above 10%"/w, indicating a reduction
in their hydrophilic nature, which correlated well with the point at which their
dissolution performance deteriorated.
As the data was obtained using rctating discs of constant surface area, the
actual amount of drug or polymer available for dissolution wifi depend on the
composition of the dispersion. To account for this, relative release rates
were calculated from the experimentally observed release rate divided by the
weight fraction of the component. This assumes that the same fraction Is
available at the dissolution surface . The relative release rate of trimethoprim
derived as above remained virtually constant up to a composition of 1O%W/w
drug, before declining rapidly at higher drug concentrations (Fig. 5.7.).
The apparent increase in relative dissolution rate at l%w/w trimethoprim
may simply be an anomalous result, but alternatively may be due to the
formation of a higher energy amorphous form of the drug with an increased
dissolution rate. X-ray diffraction studies had previously demonstrated the































































Fig. 5.7.	 Relative release rate of trimethoprim from dispersions






The identity of the controlling layer for dissolution for any composition
of solid dispersion can be determined by comparison of the relative dissolution
rates of each component. The ratios at 2%"/w and 1 0%"/w trimethoprim
are approximately one, (Table 5.5.), which suggests that bcth components
are being released simultaneously. These results are in agreement with
those reported for PEG 4000 and hydroflumethiazide or bendrofluazide solid
dispersions by Corrigan et al (1979). Conversely, for 50%"'/w trimethoprim
dispersions, the relative release rate of the polymer is much faster than that
of the drug, resulting in controlling trimethoprim boundary layer as has been
reported for suiphathiazole - PVP systems (Simonelli et al, 1969). The positive
curvature of the dissolution profiles noted with PEG 4000 alone was also evident
In the drug dissolution profiles especially at high polymer weight fractions.
This curvature was attributed to the swelling of the polymer prior to dissolution
and may therefore lend weight to the suggestion that the two components are
released simultaneously at low drug concentrations.
Since the dissolution of trimethoprim in molten PEG 4000 was known to be
incomplete for concentrations above 1%"/w, such factors as a reduction in
particle size and solid solution formation cannot be invoked as explanations
of the observed enhancement in drug dissolution. Consequently, micro-
environmental solubilisation or improved wetting and dispersibiity seem to
be Implicated. The simultaneous release of both components at low concen-
trations of drug may be indicative of the formation of soluble complexes, as
has been postulated by Corrigan et al (1979).
Comparison of the dissolution profiles of the above dispersions with those
of dispersions which had previously been molten totally at 200°C for 10 mins,
prior to cooling at 60°C hr 1 revealed only a few differences in the pattern
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of behaviour. However, the dissolution rate of trimethoprim as a function of
composition appeared to exhibit two regions of linearity, up to 5%W/w and
up to 1O%w/w (Fig. 5.8.). The gradient of the linear region up to 5%W/W
drug was calculated to be 0.264 mgmin%, which Is greater than that
oltained with the previous dispersion systems investigated. Moreover,
dissolution rates were In general higher by 10-20% from this set of completely
fused dispersions. Relative release rates from these dispersions reflected
this behaviour, but again displayed a marked decline in dissolution performance
above 10%"/w trimethoprim (Fig. 5.9.). This improvement in dissolution
behaviour, especially at low concentrations of drug, is consistent with the
formation of an amorphous form of trimethoprim suggested as an explanation
for the absence of X-ray diffraction peaks for the drug in dispersions
containing less than 5%W/w trimethoprim hapter 3.2.). Comparison of
the relative release rate of the two components again suggested that simul-
taneous dissolution occurred with 2%"7w and 10%''/w trimethoprim, but not
for 50%"iw dispersions (l'able 5.6.). This relative lack of difference In
dissolution performance between dispersions which previously had and had
not been fused tctally provides further support for the role of microeriviron-
mental solubilisation and wetting in the release mechanism. However, the
presence of a small amount of amorphous drug whose recrystallisation had
been inhibited by the polymer, possibly together with some reduction in drug
crystal size contributed to the greater dissolution rates of totally fused
dispersions compared to those In which incomplete dissolution of drug in the
polymer melt had occurred.
Quenching in liquid nitrogen of dispersions previously molten at 200°C for
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Fig. 5.9.	 Relative release rate of trimethoprim from dispersious
previously melted at 200°C for 10 mins and cooled at
60°C hr' or quenched in liquid nitrogen
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concentrations studied (l'able 5.7.), due to the formation of more amorphous
material. Since the drug existed In an amorphous state in low concentrations
of dispersions which had been fused totally during preparation, this additional
increase In the dissolution rate of the drug may be related to the decrease in
crystallinity and hence increase in dissolution rate of the PEG 4000. Thus the
degree of crystallinity of the polymer may influence the dissolution rate of the
drug. Even at 50%W/W, a threefold increase in dissolution rate of the drug
Is observed compared to the two ranges of dispersion systems prepared under
other conditions. Both McGinity et al (1984) and Hargreaves (1982) have
reported similar enhancement in the dissolution rates of drugs from rapidly
cooled dispersions with PEGS compared to more slowly cooled systems, but
the dissolution rate of the polymer was not studied in either instance.
Comparison of the relative release rate of the two components from quenched
dispersions (l'able 5.7.) reveals the same pattern of behaviour as for the
more slowly cooled dispersions, with simultaneous release of the two
components at high polymer weight fractions.
Overall It appears that changes In the crystallinity of both components
may influence the dissolution rate, but that other factors such as micro-
environmental solubilisation and improved wettability and dispersibility may
contribute strongly to the enhanced dissolution rate of the drug. It Is
interesting to note that recently Dubois and Ford (1985) produced dissolution
data for a wide variety of drugs formulated as solid dispersions with PEG 6000,
using a fusion technique, which demonstrated a remarkable similarity in the
gradients of the linear portion of the dissolution rate/% drug composition
graphs. This followed a suggestion from Corrigan (1984) that dissolution






































































they contain. Further elucidation of the mechanisms of drug dissolution
enhancement from PEG dispersions Is obviously necessary.
5.3.2.3.	 Effect of ageing
The effect of ageing on the dissolution rate of both polymer and drug for
dispersions contaIning 2, 10 and SO%'N/w trimethoprim was investigated for
systems prepared by three different methods. Dispersions were either melted
at 100°C for 10 mins and cooled at 20°Chr' or melted at 200°C for 10 mins
and either cooled at 60°Chr or quenched in liquid nitrogen. The dissolution
performance of all solid dispersions deteriorated to some extent on storage,
with the degree of change being dependent on both the concentration of drug
and the method of preparation. The deterioration was accelerated at the
higher storage temperatures of 37°C and 45°C, which is in agreement with
the data reported by Ford and Rubinstein (1979) for the indomethacin-PEG
6000 system, where ageing processes occurred more rapidly at 35°C than
4°C. Conversely, Anastasladou et al (1983) and Henry et al (1983) observed
a greater decline In dissolution rate for 10%"/w diazepam-PEG 4000 dispersions
stored at 4°C than at 37°C. This latter finding is somewhat unexpected since
higher storage temperatures w ould facilitate the secondary crystallisation
and lamella thickening processes in the polymer, resulting in a higher degree
of crystalllnity which previous studies have shown tends to decrease the
dissolution p.rformance (see preceding section).
Dispersions where complete fusion of the two components was not effected
prior to :ooling (i.e. those melted at 100°C) were known to exist as a physical
dispersion of drug particles in a crystalline polymer matrix (see Chapter
3.3.2.1.). Thus, they would not be expected to manifest large scale changes
oi ageing, since there is little potential for crystal growth of the drug and a
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high percentage of the polymer initially existed in its most stable extended
chain crystal form. The changes in dissolution behaviour for all the systems
are illustrated in terms of the percentage decrease in the relative dissolution
rate, at the highest (45°C) and lowest (25°C) storage temperatures. Changes
at 37°C were essentially similar to those at 45°C. As can be seen from the
data presented in Fig. 5.lOa. and b., a maximum decrease of — 10% in
dissolution rate occurred with these dispersions, with approximately equivalent
change in both components.
The amorphous form of the drug present in 2% W /W dispersions previously
fused at 200°C and cooled at 60°C hr 1 appeared to be relatively stable to
storage (Fig. 5.11a. and b.) with no evidence of recrystaflisation of the drug
(Chapter 3.3.2.5.) and only a small decrease in the dissolution rate of both
components. Fr3mming et al (1978) noted similar stability in 5%"/w salicylic
acid-PEG 6000 dispersions stored at room temperature where the drug was
thought to exist in the amorphous state, which was in contrast to the behaviour
of dispersions containing crystalline drug where a large drop in dissolution
performance occurred. Similarly, Ravis and Chen (1981) reported that the
dissolution performance of a lO%"/w dicoumarol-PEG 4000 was unchanged
after a year's storage at room temperature. Again, the drug was postulated
to exist In a "high energy" amorphous form. In a study of factors affecting
the extent of recrystallisation from an indomethacin-PEG 6000 system, Saboe
and Dempski (1976) demonstrated negligible recrystallisation below a "critical
supersaturation concentration", estimated at 3.7%w/w for their system.
Thus it appears that recrystallisation of small amounts of amorphous drug
in crystalline PEGS will be inhibited, possibly indefinitely due to the extreme





Fig. 5.10. Effect of ageing on the relative dissolution on rate of solid
dispersions previously melted at 100°C for 10 mlns prior
to cooling at 20°C hr and stored at:
(a) 25°C
Keyto Figs. 5.10-5.12
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Fig. 5.11. Effect of ageing on the relative dissolution rate of solid
dispersions previously melted at 200°C for 10 mins and
cooled at 60°C hr 1 , stored at
(a) 25°C
0	 30	 60	 90	 120	 150	 180
Storage time (days)
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Fig. 5.12. Effect of ageing on the re]ative dissolution rate of dispersions
previously melted at 200°C for 10 mins and quenched in liquid
nitrogen
(a) 25°C













Fig. 5.12.	 b) 45°C
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However, 1O%"/w and 50%W/w dispersions prepared similarly displayed a
greater decrease in dissolution rate than those containing 2%"/w trimethoprim.
Presumably, the fine crystallites of drug present tend to encourage further
crystal growth. Additionally, for 50%"/w dispersions, a fairly high proportion
of PEG 4000 existed as metastable folded chain crystals or had nct crystallised
due to the hindering effect of the drug crystals, resulting In a significant
decrease In dissolution rate on ageing as reversion to the most stable form
and an increase in crystallinity occurred.
Hoelgaard and Møller (1975b) reported the largest decrease In dissolution
rate on storage with testosterone dispersions formulated with PEGS 4000 or
6000, compared to those with PEGS 1000 or 20, 000. This may well be related
to the inherent Instabifity of tbe folded chain crystals of PEG likely to be found
in the 4000-6000 molecular weight range, which as they convert to the extended
chain form tend to destabiise the entire dispersion. PEG 1000 can only exist
as extended chain crystals and for PEG 20, 000, the most stable ccxiformation
is as folded chain crystals, thus these systems would be expected to exhibit
greater resistance to the effects of ageing.
Quenched dispersions displayed the greatest decrease in drug dissolution
performance on ageing (Fig. 5.12a. and b.), which appeared at the lower
concentrations of drug to be related to the recrystallisation of the polymer.
No evidence for the recrystallisation of the drug at 2%"'/w or 1O%"/w, except
after 6 months in the latter case, could be detected from X-ray diffraction
studies hapter 3.3.2.5.). This seems to support the contention that the
crystaLUnity of the carrier may exert an influence on the dissolution rate of
the drug. Dispersions containing 50%W/W trimethoprim aged more rapidly
than the lower concentration dispersions, since presumably as before, once
- 288 -
recrystaillsation commenced, then the crystallites encouraged further growth.
In conclusion, the greatest stability of solid dispersions to ageing was
displayed by samples which either contained low concentrations of drug or
where incomplete fusion of the two components occurred before cooling.
Furthermore, low storage temperatures and a slow rate of cooling contri-




Knowledge of the influence of thermal history on the morphology of
PEG 4000 and its solid dispersions is obviously important if these materials
are to be formulated as molten filled hard gelatin capsules. Characterisation
of the structure of solid dispersions has typically been performed by the
construction of a temperature-composition phase diagram, often from DSC
data, as was carried out here for the PEG 4000-trimethoprim system.
An unambiguous interpretation of such data can be difficult in the absence
of a melting transition for the drug at low concentrations, especially as it
is in this region that solid solution and eutectic formation has been potu1ated
by many workers hicu and Riegelman, 1971; Hargreaves, 1982; Hoelgaard
and Møller, 1 975a). Furthermore, depression of the melting point of the
polymer is n necessarily indicative of the presence of a eutectic.
Additional Information can be gained about the structure of solid dispersions
from the relationship between composition and the enthalpies of melting or
crystafllsation of the components as measured by DSC, but again may be
difficult to interpret for systems containing low concentrations of drug.
Likewise, X-ray diffraction studies provided much information about the
structure of these systems, but cannct be used to distinguish between low
concentrations of drug in the amorphous form or a solid solution of drug in
a semi-crystalline carrier. Thus although DSC and X-ray diffraction are
very useful techniques, limitations exist in that analysis of the data is
sometimes open to several interpretations. Therefore a definite description
of the structure of such systems is nct always possible.
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The technique of dielectric spectroscopy, which had nct previously been
applied to the study of pharmaceutical solid dispersions, was found to provide
a good description of their structure when modelled in terms of the Dissado-
Hill theory,which corrcborated that inferred by DSC and X-ray diffraction
studies • A particular advantage of this method was that it allowed investi-
gations over a wide range of temperatures In the liquid and solid and during
temperature cycling, thus providing Information which was nct readily
accessible from the cther techniques. Measurements of dielectric response
may have considerable pctential in the evaluation of other pharmaceutical
systems. Preliminary work on the characterisation of emulsions and powders
from their dielectric behaviour has already provided encouraging results.
All the above techniques indicated that PEG 4000 and trimethoprim did
nct form a solid solution or eutectic to any detectable extent, under any of
the preparative conditions investigated. Moreover, considerations of the
mechanism of crystallisation and crystal structure of PEG 4000 suggest that
the formation of solid solutions with drugs is probably much less widespread
than originally postulated. CrystaUisation of the trimethoprim was inhibited
to some extent in the presence of the polymer, resulting in the formation of
amorphous drug. Thus solid dispersions of PEG 4000 and trimethoprim
existed mainly as a physical dispersion of the drug crystals in the semi-
crystalline polymer matrix. The proportion of amorphous drug and polymer
formed varied, depending on the previous thermal profile.
The thermal history of PEG 4000 was found to influence its resultant
morphology in terms of bcth the degree of crystalllnity and the extent of each
crystal type - either extended or thermodynamically metastable, folded chain
lamellae. The temperature of melting and time In the molten state however,
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exerted a lesser influence on the subsequent morphology of the polymer than
did variations In the cooling rate • A similar pattern of behaviour was observed
for the solid dispersions with trimethoprim.On ageing, reversion of the folded
chain crystals of PEG 4000 to the extended chain form invariably occurred,
by a process of chain unfolding and lamellar thickening.
As has often been demonstrated in the past, the formulation of sparingly
soluble drugs such as trimethoprim as solid dispersions greatly improves
their dissolution performance. The properties of solid dispersions can be
influenced by thermal history, especially by quenching samples in liquid
nitrogen to produce a more amorphous form of the drug and polymer.
Quenched dispersions exhibited faster dissolution rates of bcth drug and
polymer and may offer a method by which the carrying capacity of such
systems can be extended. The carrying capacity of solid dispersions has
always limited their use to the formulation of low dosage drugs, since the
enhancement of dissolution rate is only usually apparent up to concentrations
of approximately l0%W/w drug in carrier. Quenched dispersions displayed
an improved dissolution performance at higher concentrations of trimethoprim
than the more slowly cooled solid dispersions.
Since solid solution and eutectic formation is negligible here, this cannct
be the reason for the improvement in the dissolution profile of trimethoprim.
The enhanced dissolution rate of the drug prohably results from a combination
of different mechanisms such as microenvironmental solubilisation, improved
wetting, some reduction of particle size and the formation of amorphous
drug. The quenched dispersions displayed the fastest dissolution rate due
mainly to the formation of amorphous drug, but the faster dissolution rate of
the more amorphous PEG 4000 may also be influential In this improvement.
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Simultaneous release of drug and polymer appears to occur up to concentrations
of —1O%"/w trimethoprim, beyond which the dissolution of the polymer is
increasingly more rapid than that of the drug.
Further elucidation of the mechanisms of enhanced dissolution rate and
their relative importance is fundamental to the understanding of these systems.
Qie problem with the formulation of drugs as solid dispersions is the decrease
in dissolution performance on ageing, which appears to be at least partly
related to the increase in crystallinity and conversion to extended chain crystals
of the PEG 4000. Hoelgaard and MUer (1975b) reported a greater deterioration
in dissolution performance with drugs formulated in PEGS 4000 and 6000 than
with those in PEGS 1000 or 20, 000. Thus selection of a PEG with a molecular
weight outside of the 4000-6000 range, where the greatest degree of chain
unfolding would be expected to occur might reduce the effects of ageing.
The importance of characterising the molecular weight distribution of the
polymer has in the past been overlooked. It is,however,important because
of Its influence on the stability of the various crystal forms present and hence,
their rate of conversion to a thermodynamically more stable form. This is
especially Important in the m.wt range 4000-6000, since for example, the
rate of conversion of folded to extended chain crystals has been reported to
be 50 times greater for PEG 4000 than PEG 6000 (Buckley and Kovacs, 1976).
The influence of molecular weight on formulation and dissolution properties
could be utiised in that blends of low and high molecular weight PEGS may
be used to achieve the desired dissolution profile, but maintain good handling
properties.
To confirm the improved dissolution performance of trimethoprim solid
dispersions, In vivo studies are of course necessary to establish whether
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improvements in drug absorption are possible, as improved bicavailability
will only occur for those drugs whose absorption Is dissolution rate controlled.
The variations in thermal profile that might be encountered during the
molten filling process are unlikely to Influence significantly the properties
of the final product In terms of dissolution performance. However, it would
be advisable to keep the temperature of the melt as low as possible to minimise
thermal degradation of the product. For this reason also, the period of time
In the molten state should be minimised. The susceptibility of a particular
formation to theriml decomposition will obviously vary with the stability of
the drug, however suspensions of particles of drug In the polymer melt in
comparison to full solution melts, may be expected to exhibit greater thermal
stability at elevated temperatures. In view of the practically equivalent
dissolution performances of solid dispersions where the two components were
and were n totally fused during preparation, the latter type may well be
preferred on stability grounds. Darkening of the polymer melt on prolonged
storage at high temperatures may affect the appearance of the resultant
product, but its influence on drug stability is probably minimal. Although
cooling rate does influence the dissolution rate of the product, within the
range of cooling rates experienced by molten filled capsules, there should be
a negligible effect on dissolution performance. The application of stricter
thermal controls than currently employed during molten filling is likely
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